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ABSTRACT 
 
This thesis is studying on the Design and development of a biomechanical robotize IPC 
device to accomplish a therapeutic methodology for recovery of cardio-circulatory 
functions, which may be seriously impaired in paraplegic patients. This impairment is 
caused by the reduction of venous return, due to the missing muscular contraction in 
zones without innervations. 
Intermittent Pneumatic Compression (IPC) is a well-known technique, which can be used 
for several therapeutic treatments like sports recovery, lymphoedema drainage, and deep 
vein thrombosis prevention. An IPC device produces a definite massaging action on the 
limb by inflating and deflating a given number of bladders according to particular time 
laws. 
The designed IPC device in this thesis is proposed for the lower limb to recover the 
venous return and preventing the Deep Vein Thrombosis (DVT) in the patients. The 
experimental tests on the volunteer persons showed the significant improvements on the 
important parameters of the cardiovascular, like the stroke volume (SV), the cardiac 
output (CO), and the end diastolic volume of left ventricle (LVEDV).  
To understand the dynamic behaviour of the IPC device and to optimize its performances, 
the device is characterized based on the mechanical and physiological aspects and its 
mathematical model is simulated in Simulink-Matlab. The validation of the mathematical 
model is done by comparing results with the experimental one.  
In addition, to apply the desired pressure pattern on the limb, two control strategies based 
on the PID algorithm and regulating inflating time are implemented on the model. The 
results of the controlled model, shows about 60% improving in performances of the 
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device as concerns the bladder pressure control. In this case the experimental test has been 
done and it verified the control results of the simulation. 
 
Keywords: cardiovascular efficiency, IPC device, mathematical modelling, controls 
strategies. 
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1. INTRODUCTION 
 
In immobilized people, e.g. paraplegic subjects, due to absence of leg muscle contraction, 
venous return to the heart is reduced and this may induce a reduction of cardiac output. As 
a matter of fact, according to the well-known Starling’s law, “the output of the heart is 
equal to and determined by the amount of blood flowing into the heart, and may be 
increased or diminished within very wide limits according to the inflow”. In other words, 
the cardiac output is directly influenced by the venous return, which is determined 
primarily by the mechanical properties of the systemic circulation. 
Therefore it is reasonable to suppose that, the application to legs of a mechanical 
stimulation operated by actuators, in replacing striate muscle pump on limbs veins, may 
recover in these patients venous return to the heart, thus restoring sufficient performance 
of the cardiovascular system. 
Since 1930s, it was evaluated that intermittent pneumatic compression (IPC) has a 
positive effect on lower extremity blood flow of the calf and foot [1, 2]. IPC devices were 
therefore used to prevent deep vein thrombosis (DVT) [3-7], Critical Limb Ischemia 
(CLI) [8-10], congestive heart failure [11] and it was recommended for lymphedema 
treatment [12] and sport recovery [13, 14]. Studies have shown that IPC application on 
legs changes central venous pressure, pulmonary artery pressure, and pulse pressure [15] 
and IPC application on foot increases popliteal artery blood flow [16]. Moreover various 
researches have suggested that this mechanical method effectively reduces the incidence 
of the diseases without any side effects, increasing volume flow and velocities in deep 
veins [10, 11, and 17].  
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Although the various forms of mechanical intermittent compression of limbs have a 70-
year history of published clinical effectiveness, a complete knowledge of the cause and 
effect process is not yet fully reached. 
Despite there are many researchers investigating on IPC effects, the lack of a general 
methodology to study and develop an IPC device with physical and dynamical 
characteristics suitable for the intended application, is evident. In particular, the dynamic 
behaviour of the device in response of the control command is practically ignored. 
This research proposes and realizes a new prototype of IPC device to act on the lower 
limb to specialty recover the venous return in the immobilized and paraplegic patients. In 
addition, a methodology based on the realization of a mathematical model to represent the 
dynamic behaviour of the device and its interaction with human is proposed.  
To optimize the performances of the model, two control strategies based on the PID 
algorithm and regulating inflating time are implemented on the model. Moreover, the 
results of the experimental test to verify the simulation results are presented.  
 
 1.1 Thesis outlook 
The thesis is organized into 7 chapters followed by the three included papers. After this 
short introduction, the aims are stated. The physiology of the cardio circulatory system 
and the related diseases and the ways to prevent and treatment of its diseases are described 
in Chapters 3. Chapter 4 provides a literature review of using IPC device to effect and 
improve the cardiovascular function as well as describe briefly the commercial IPC 
devices in the market and finally introduces the design IPC device in this research. The 
experimental results of the IPC device on the volunteer people to show the effect of the 
IPC device on cardio circulatory function are shown also in this chapter. The obtained 
mathematical model of the device and its validation are presented in the chapter 5. In 
chapter 6, two control strategies to control the device are described and the experimental 
results of the PID controller are depicted. Finally in chapter 7 the conclusion of the thesis 
is provided.  The future work, other scientific contributions by the author and references 
are presented in the last part of the thesis. Also the three published Papers based on the 
thesis in full format are presented in the index part. 
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 2. AIMS 
 
The general aim of this thesis is to develop and realize a biomechanical robotized IPC 
device to accomplish a therapeutic methodology for the recovery of cardio circulatory 
functions, seriously impaired in paraplegic patients. The aim originates from the 
knowledge of cardio circulatory system malfunctioning in patients with spinal injury. This 
impairment is caused by the reduction of venous return, due to the missing muscular 
contraction in zones without innervations. Such impaired patients have therefore, in 
comparison to healthy subjects, a higher death risk due to cardiovascular pathologies and 
particularly the coronary disease. 
The device mechanically interact with the patient and is equipped with own auctioning 
and control systems, to produce a massaging-pumping action on the striated muscles of 
the lower limb according to control laws.  
The specific aims of the research can be listed into 3 parts which in the below are 
described. 
 
 Design and realization of a new IPC device. The device must be different from the 
previous samples in the performances on the patients. 
 Propose a methodology based on the realization of a mathematical model able to 
represent the dynamic behaviour of the device and its interaction with the human. 
 Control of the device to exert a desired pressure pattern on the limb. This causes to 
increase the efficiency of the device for improving the cardiovascular parameters. 
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3. PHYSIOLOGY OF THE CARDIOVASCULAR 
SYSTEM 
 
This chapter contains an overview of the anatomy and the function of the cardiovascular 
system and provides brief descriptions of some of the most common cardiovascular 
diseases, and some ways to prevent and treatment of them. The cardiovascular system 
consists of the heart, blood vessels and blood, and is responsible for the transportation of 
gases, nutrients, hormones and blood cells throughout the body. Additional functions of 
the cardiovascular system are to regulate body temperature and acid-base balance. 
  
3.1 Cardio circulatory system 
The main function of the cardio-circulatory system is to transport useful substances in the 
metabolism of the cells and remove the waste substances through the body.  The cardio-
circulatory can be divided into two parts, systemic circulation and pulmonary circulation. 
Through the systemic circulation, the oxygenated blood from the heart is come to the 
organs by the arterial and the deoxygenated blood is returned to the heart by the veins. In 
addition, the pulmonary circulation transports the deoxygenated blood from heart to lungs 
and brings back to the heart the fresh oxygenated blood. In the figure 3.1, the cardio-
circulatory of the body is depicted. The energy of the blood circulation through the veins 
comes from the heart. 
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Figure 3.1. The cardio-circulatory system of the body 
 
 3.2 Heart anatomy 
The human heart is a muscular pumping organ located medial to the lungs along the 
body’s midline in the thoracic region. It has a weight of approximately 250-300 g and a 
size similar to a closed fist [18]. The heart is divided into a left and a right side. Each side 
of the heart consists of two chambers, the atrium and the ventricle, separated by an 
atrioventricular (AV) valve: the mitral and the tricuspid valves on the left and right sides, 
respectively.  The anatomy of the heart is depicted in figure 3.2. 
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Figure 3.2. Anatomy of the heart 
 
The left side of the heart delivers oxygen-rich blood to the body (systemic circulation) 
passing through the aortic valve to the aorta, whereas the right side pumps blood through 
the pulmonary valve and the pulmonary artery for an oxygen refill in the lungs 
(pulmonary circulation). The four heart valves act as inlet and outlet check-valves for the 
ventricles, allowing unidirectional flow and preventing backflow by being passively 
opened and closed due to pressure gradients.  
 
3.2.1 The cardiac cycle 
The right and the left sides of the heart operate as two serial pumps, performing the 
pumping work fairly synchronously in the normal heart. The cardiac cycle consists of the 
two main phases: systole, referring to the period of ventricular contraction and ejection of 
blood out of the ventricles, and diastole, being the period of ventricular relaxation and 
filling. In the figure 3.3, the systole and diastole phases are shown. 
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Figure 3.3. The systole and diastole phase of the heart 
 
The myocardial contraction is initiated by automatic generation of an electrical impulse in 
the sinus node located in the superior lateral wall of the right atrium. The contraction 
results in a pressure rise within the ventricles. The phase when pressure increases most 
rapidly is called the isovolumic contraction time (IVCT), since all valves in the heart are 
closed and the ventricular volume is constant. When the pressures in the ventricles exceed 
the pressures in the aorta and the pulmonary artery, the aortic and pulmonary valves open 
and the ventricles eject blood. The blood travels along the cardiovascular system, driven 
by the pressure gradient generated by the myocardium. Blood from the body and the lungs 
starts to fill the atria of the heart, simultaneously with ventricular ejection. The pulmonary 
and aortic valves close when the pressures in the aorta and the pulmonary artery exceed 
the ventricular pressures. 
When the ventricular myocardium starts to relax, the ventricular pressures drop rapidly. 
Once again, all valves in the heart are closed during the isovolumic relaxation time 
(IVRT). The pressures in the 
Blood-filled atria increase, which leads to mitral and tricuspid valve opening to let the 
blood flow into the ventricles. During the first part of the ventricular filling phase, the 
blood flows as a result of the pressure gradient between the atria and the ventricles. This 
phase is called the fast filling phase or the early diastolic wave (E-wave). The filling 
continues after the E-wave, but at a reduced rate during the phase called the diastasis [19]. 
This phase is followed by atrial contraction during the atrial diastolic wave (A-wave), 
contributing to the ventricular filling by lifting the AV-plane. The pressures inside the 
Systol
e 
Diastol
e 
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ventricles rise with the increased filling and, finally, the blood is pushed up against the 
mitral and tricuspid valves, forcing them to shut. Thereafter a new cardiac cycle can 
begin. Myocardial perfusion mainly occurs during diastole, as a consequence of 
increasing resistance in the coronary arteries during systole. 
 
 3.3 Cardiovascular function 
The most important factors governing the function of the circulatory system are volume, 
pressure, resistance, and flow. Blood flow is determined by two factors: a pressure 
difference between the two ends of a vessel or group of vessels, and the resistance that 
blood must overcome as it moves through the vessel or vessels. The relation between 
pressure, resistance, and flow is expressed by the equation F = P/R, in which F is the 
blood flow, P is the difference in pressure between the two ends of the system, and R is 
the resistance to flow through the system. In the circulatory system, blood flow is 
represented by the cardiac output (CO), affected by the viscosity of blood and determined 
by the cross-sectional area of a vessel. 
Cardiac output (CO) is the term used to describe the amount of blood pumped by each 
ventricle per minute. The left ventricle and the right ventricle have the same cardiac 
output despite the differences in their architecture – it must be that way or an 
accumulation of blood would exist on one side of the circulatory system causing 
catastrophic consequences. Cardiac output is calculated by the following formula, CO = 
SV * HR, where SV is stroke volume and HR is heart rate. A non-athlete pumps about 20 – 
25 L of blood per minute [20]. 
Stroke volume is the amount of blood ejected from the heart by each heartbeat, and the 
heart rate is the number of times the heart beat in one minute. Stroke volume is related to 
the strength of contraction of the ventricle. The average ventricle contraction leaves some 
blood volume left within the ventricle. The stronger a ventricle’s contraction, the less 
blood is left once systole is over [20].   
The amount of stroke volume can be changed in three ways. The first way is by changing 
the initial volume within a ventricle at the start of systole (also known as the end-diastolic 
volume (EDV)).  The Frank-Starling Mechanism is the formal name given to describe the 
relationship between stroke volume and end-diastolic volume. An increase in the amount 
of blood occupying a ventricle after diastole results in an increase in contraction. The 
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stronger contraction is a result of the increased amount of blood creating an increased 
tensile preload on the muscle fibres of the ventricle, creating a greater force of 
contraction. The Frank-Starling Mechanism kicks in when there is an imbalance of rate of 
blood flow between separate sides of the heart. If one side of the heart begins to pump 
blood at a faster rate than the other, the side of the heart with the slower rate of blood flow 
will demonstrate an increase in venous return, creating a higher EDV in the ventricle, 
instigating a stronger contraction resulting in a greater stroke volume [20].  
The second way is by input from the sympathetic nervous system. The sympathetic 
nervous system mobilizes the body’s resources during times of stress. When greater 
cardiac output is required, the body can create stronger ventricular contraction that results 
in greater stroke volume [20].  
The third way stroke volume can be changed is through a change in arterial pressure in 
which the ventricles must empty into. An increase in afterload (the pressure exerted by the 
arteries onto the ventricle) usually decreases stroke volume because the increased load 
prevents full contraction of the ventricle’s muscle fibres [20]. 
 
 3.4 Cardiovascular diseases 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood vessels. 
Cardiovascular disease still kills more people in Europe and North America than any other 
disease. It is the number one cause of death among women and men in the United States 
and many other developed countries [21-23]. The statistics from developing countries 
paint a similarly bleak picture. There were approximately 17 million deaths due to CVD 
in 2003 accounting for one third of all deaths in the world. For example strokes kill nearly 
6 million [24].  
CVDs include: 
 Coronary heart disease or coronary artery disease – disease of the blood vessels 
supplying the heart muscle;  
 Cerebrovascular disease - disease of the blood vessels supplying the brain; 
 Peripheral arterial disease – disease of blood vessels supplying the arms and legs; 
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 Valvular disease – damage to the heart muscle and heart valves from rheumatic 
fever, caused by streptococcal bacteria; 
 Congenital heart disease - malformations of heart structure existing at birth; 
 Deep vein thrombosis and pulmonary embolism – blood clots in the leg veins, 
which can dislodge and move to the heart and lungs. 
 
3.4.1 Coronary artery disease 
Coronary artery disease (CAD) is the term for atherosclerosis in the coronary arteries. 
Atherosclerotic disease is the development of artery wall thickening and calcification, due 
to accumulation of lipids within the arterial intima resulting in atherosclerotic plaques. 
Atherosclerosis leads to increased peripheral resistance in the vascular system resulting in 
higher work-load for the myocardium and, in some cases also to a severe narrowing of the 
vessel lumen due to building of focal plaques leading to obstruction of the blood flow 
(stenosis). This can lead to myocardial ischemia, which is a lack of oxygen as the result of 
a perfusion imbalance between supply and demand. Prolonged ischemia can lead to 
myocardial infarction, i.e. regional myocardial cell death/necrosis [25]. 
CAD is usually the underlying cause of ischemia and myocardial infarction. Stable CAD 
is associated with chronic stenosis/-es in the coronary arteries, leading to symptoms, most 
often chest pain (angina) due to ischemia at a certain workload. Moreover, stable CAD is 
characterized by unchanged or slowly progressing symptoms over time. A sudden change 
of symptoms is associated with unstable CAD, often due to a plaque rupture leading to 
thrombus formation in the artery. When a plaque ruptures and subendothelial vessel 
structures come into contact with the blood, a thrombus formation is trigged, creating a 
dynamic stenosis or occlusion in the coronary artery. Unstable CAD carries a high risk of 
cardiac death and/or myocardial infarction and requires urgent medical treatment. 
 
3.4.2 Cerebrovascular disease 
Cerebrovascular disease is a disease of blood vessels supplying the brain and it causes a 
group of brain dysfunctions. The most important cause is Hypertension; it damages the 
blood vessel lining, endothelium, exposing the underlying collagen where platelets 
aggregate to initiate a repairing process which is not always complete and perfect. 
Sustained hypertension permanently changes the architecture of the blood vessels making 
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them narrow, stiff, deformed, uneven and more vulnerable to fluctuations in blood 
pressure. The results of cerebrovascular disease can include a stroke or occasionally a 
hemorrhagic stroke. Ischemia or other blood vessel dysfunctions can affect the person 
during a cerebrovascular incident [26]. 
 
3.4.3 Peripheral arterial disease 
Peripheral arterial disease is a progressive disease which includes stenosis and occlusions 
in the peripheral arterial bed. The commonest manifestation of PAD is in the lower limbs 
and it can be symptomatic or asymptomatic. In the legs, the symptoms range from 
intermittent claudication (IC) to critical limb ischemia (rest pain, ulceration and/or 
gangrene). Most cases of PAD are, however, asymptomatic. Depending on the site of the 
arterial tree affected, the patient may also present with mesenteric angina (abdominal pain 
after meals), transient ischemic attacks or stroke, renal failure (renal artery disease) or 
myocardial infarction. Common manifestation of arterial disease is in the lower limbs, 
where, patients present with IC. IC manifests as muscle pain in the lower limbs on 
exercise. The muscle groups affected will depend on the level of arterial tree occluded. 
Aorto-iliac occlusive disease patients will have thigh or buttock pain and femero-popliteal 
occlusion will present with calf muscle group pain. More importantly, atherosclerosis may 
cause or worsen multi-level disease in segments of the arterial tree that are already 
diseased, so that the same patient may have both aorto-iliac and femero-popliteal disease. 
The pain rapidly improves on cessation of exercise/walking. 
PAD risk factors are almost identical to those of developing atherosclerosis disease 
elsewhere. The most important risk factors are smoking, the male gender and diabetes. 
[27]  
 
3.4.4 Valvular disease  
Valvular disease refers to the improper functioning of the valves of the heart for various 
reasons. For individuals who have mild versions of valvular disease, undergoing thorough 
examination by a trained physician is usually the only way to diagnose the problem. 
Valvular disease will often be diagnosed by a doctor when an abnormal sound known as a 
murmur signals the malfunctioning of a valve initiating further investigation [28].  
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A mild problem with a heart valve can take years to grow to become congestive heart 
failure because the heart is able to adjust its own performance to make up for problems 
with the valve. Problems with other parts of the cardiovascular system that force the heart 
to work even harder together with mild valvular malfunction is usually what causes the 
heart to weaken [28].   
The regularity of valvular disease is not clearly defined in the medical world. While 
almost one in twenty persons have a mild congenital form of what is known as mitral 
valve prolapse (the mitral valve does not cover the annulus completely), only one in half a 
million people suffer from valvular disease that affects adequate pumping to the body by 
the heart. Diseases of the valves are named by identifying the affected valve and whether 
the valve is stenotic (narrowed) or regurgitant (leaking). Mitral valve stenosis is an 
example of the nomenclature for a given valvular disease [28].  
Common causes of valvular disease include congenital defects (a malformation during 
fetal development), calcium deposits that form as people age, and valvular infections. 
Less commonly, the deterioration of valvular supportive tissue (the valve no longer seals 
tightly due) as well as aortic aneurysm (the dilated aorta is too wide for the aortic valve to 
cover sufficiently) can also cause disease of the valves. Valvular disease affecting the left 
side of the heart is a much more serious problem than disease of valves on the right side 
due to the much higher pressure loads that must be withstood on the left side of the heart 
[28].   
Rheumatic fever and infectious endocarditis are two infectious diseases that can cause 
disease of the heart valves. Rheumatic fever is caused by the same strain of bacteria that 
causes strep throat and can infect the heart valves if improper treatment allows for 
spreading of the bacteria to the heart. The bacteria cause inflammation of the lining of the 
heart and heart valves, almost always in the mitral valve, and half of the time in the aortic 
valve.  
Stenotic valves can be caused in many ways – heart attack, congestive heart failure, aging, 
or cardiac/aortic aneurysm. In all cases, the support structures of the valve stiffen and the 
valve loosens resulting in valvular disease and allowing for regurgitation of blood [28].   
Mitral stenosis is caused most often by Rheumatic fever, and less frequently by the aging 
process that results in the calcification of the valve. Severe cases of mitral stenosis cause a 
backup of blood in the left atrium, distending the atrial wall. The atrium in turn attempts 
to compensate for the overfilling over time by thickening so that it can pump blood more 
forcefully. An enlarged left atrium may inherit rhythm irregularity known as atrial 
Physiology of the cardiovascular system                                                                           14 
 
 
fibrillation where the atrium no longer contracts. Eventually, blood backs up through the 
pulmonary vein and into the lungs causing pulmonary edema. Pooled blood in the atrium 
can also clot. If a small piece of the clot in the atrium breaks off into the bloodstream, it 
could lead to infarction in some other region of the body [28]. 
Aortic stenosis is commonly caused by the aortic valve only having two leaflets. A 
bicuspid aortic valve becomes stenotic more easily because it more easily calcifies. Aortic 
stenosis causes the left ventricle to undergo hypertrophy to generate the much higher 
pressures that the diseased valve imposes on the ventricle to force blood into the body. 
Eventually the left ventricle hypertrophy leads to congestive heart failure with all its 
aforementioned symptoms [28]. 
 
 
3.4.5 Congenital heart disease 
Congenital heart disease (CHD) is among the most common congenital abnormalities and 
involves structural anomalies of the heart and/or related major blood vessels. Many types 
of heart defects exist, most of which either obstruct blood flow in the heart or vessels near 
it, or cause blood to flow through the heart in an abnormal pattern. CHD arises in the first 
trimester of pregnancy, occurring often and in many forms. It is the leading cause of 
infant mortality [29] and contributes to 30% to 40% of all deaths during infancy and early 
childhood [30]. 
The morbidity varies with the severity of the CHD and can be quite serious and life 
threatening. The multiple surgeries needed to correct the anatomical defects can be 
debilitating. Furthermore, the quality of life of these patients is often compromised due to 
severe physical as well as psychological problems. 
Over the past decades the diagnosis, medical care and surgery have considerably 
improved the prospects for children with CHD and resulted in a significant decrease of 
CHD mortality and morbidity [31]. Nowadays approximately 85% of children with CHD 
survive. Therefore, the primary prevention of CHD would be a big step forward, being 
only possible when more insight is gained into the embryogenesis of the heart and the role 
of genes and environmental factors. 
CHDs appear in many forms and affect most parts of the heart. Cardiomyopathies, 
conduction-system disease and laterality defects, are inherited and sometimes present at 
birth, but are often not considered CHDs because of their distinct clinical presentation. 
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CHDs are associated with other anomalies or occur as part of a syndrome, but are most 
frequently present as an isolated malformation. 
 
3.4.6 Deep vein thrombosis  
Deep vein thrombosis is a serious condition with potentially fatal consequences. Many 
patients in both hospital and the community are at increased risk of DVT, and it is 
therefore important for nurses to understand the condition and how to recognize it.  
Veins have a hollow core (lumen) through which blood flows from the tissues back to the 
heart. They contain valve cusps and are composed of three layers. The inner layer is 
composed of endothelial lining, the middle layer is composed of smooth muscle and 
elastic tissue, and the outer layer is composed mainly of elastic and collagenous fibers. In 
figure 3.4, the components of a vein are shown. 
 
 
Figure 3.4. The components of a vein 
 
Venous blood flow is assisted by respiration, which causes pressure changes in the thorax 
and abdomen, and by skeletal muscles and valve cusps. During mobilization the skeletal 
muscles of the lower limbs contract, causing the valves to open and forcing blood towards 
the heart (the calf muscle pump). When the muscles relax, the valves close to prevent 
backflow. In figure 3.5, the skeletal muscle pump is depicted.  
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Figure 3.5. The skeletal muscle pump 
 
 DVT is the formation of a thrombus in a deep vein. Venous thrombosis are comprised 
mainly of fibrin and red blood cells. Although it usually affects the leg veins, DVT can 
occur in the upper extremities, cerebral sinuses, hepatic, and retinal veins. In figure 3.6 the 
schema of the deep vein thrombosis is shown. 
 
 
Figure 3.6. Schema of the deep vein thrombosis 
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It is usually caused by a combination of predisposing factors known as Virchow’s triad 
after the German pathologist who discovered them: 
  Venous stasis: immobility reduces the effectiveness of the calf muscle pump and 
can lead to stasis (slowing of blood flow) and pooling of blood behind the valve 
cusps; 
  Vein wall trauma/dilation: local trauma (for example, orthopaedic surgery or leg 
fracture) to the endothelial lining of the vein wall activates clotting by triggering 
the release of tissue factor. Venous dilation, which may occur intraoperatively, can 
cause endothelial damage resulting in the exposure of collagen and activation of 
clotting; 
 Hypercoagulability: a variety of hereditary and acquired causes of increased 
coagulability, such as pregnancy, malignancy, and thrombophilia. 
 All hospital patients should be assessed for clinical risk factors of DVT. The risk in 
surgical and orthopaedic patients is well recognized but medical patients (for example 
patients with myocardial infarction, stroke, or heart failure) are also at high risk and 
should receive thromboprophylaxis as appropriate. 
 
3.5 Deep vein thrombosis prophylaxis 
The basis of DVT prophylaxis is to target the triad of predisposing factors: venous stasis; 
vein wall trauma/dilation; and hypercoagulability. 
 Mobilisation and breathing exercises 
Nurses can encourage mobilisation and leg exercises in at-risk patients in order to activate 
the calf muscle pump. Breathing exercises will also help venous return. Patients should be 
advised to observe for signs and symptoms that suggest DVT and inform nurses if 
concerned. 
 Antiembolism stockings  
Antiembolism stockings (AES) provide continuous stimulation of linear blood flow, 
prevent venous dilation [32], and stimulate endothelial fibrinolytic activity [33].  
 Anticoagulants 
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Anticoagulants such as low-molecular-weight heparin (LMWH) increase the action of 
antithrombin and inhibit a number of coagulation proteins. LMWH can be administered in 
a prophylactic dose, usually via subcutaneous injection, with a predictable anticoagulant 
response. In moderate-risk patients use of AES may be combined with anticoagulants to 
minimize risk. Patients require careful observation as anticoagulants can cause bleeding, 
and any side-effects should be reported. 
 Intermittent pneumatic compression  
Intermittent pneumatic compression (IPC) is a device to produce defined 
compression/relaxation patterns on limb surface to improve the venous return and to 
prevent of the deep vein thrombosis in the lower limb. This action can be done by a given 
number of actuator to stimulate mechanically the limb. So, by replacing striate muscle 
pump on limb veins, the venous return may recover in the immobilized patients. In the 
next section the IPC device is described completely. 
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4. IPC DEVICE 
 
This chapter presents general information about intermittent pneumatic compression (IPC) 
device. The general structure and the background of using IPC device to recover 
cardiovascular system are explained. In addition, the designed IPC device is described and 
the experimental results of the effectiveness of the device in cardio circulatory function 
are expressed.  
  
4.1 General structure of an IPC device 
IPC device is a device for exerting an intermittent pressing action on the lower limb, to 
the aim of improving the venous return in impaired people, like paraplegics. However, the 
same concept could concern any device aimed at exerting a compressing action, like a 
massage for lymphoedema treatment or sports recovery. 
A typical structure of such a device could be the one depicted in figure 4.1. In this case it 
is provided with a given number of inflatable bladders (a), included into shells (b, c), and 
acting on the skin of the calf and foot. The shells could be rigid or, more conveniently, a 
sort of sleeves, flexible but inextensible, so self-adapting to the shape and size of the limb 
but also avoiding stretching and therefore directing all the pneumatic energy towards the 
limb. 
The control system can be arranged with several levels of complexity; basically it must 
include a group of valves (d) and a programmable logic controller, i.e. a PLC (e); for 
given applications it may be convenient to include also some sensors, for dynamic 
monitoring of air pressure inside bladders or contact pressure to the skin. 
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Figure 4.1. Typical configuration of an IPC device 
 
The operating of the device is simple: by inflating the bladders with the compressed air, 
the pressure can be applied to the limb surface. Moreover, the programmable logic 
controller (PLC) controls the valves with a defined time sequence, so as to arrange the 
sequential acting to the bladders and generate a peristaltic and centripetal pressure wave 
on the limb. 
 
4.2 Background of using IPC (literature review) 
During any physical activity, the intermittent contraction of the limb muscles exerts 
important pumping actions on physiological systems such as the muscular, cardiovascular 
or lymphatic system. When the muscular efficiency is compromised for some reason, its 
function can be mimicked by a mechanical device properly conceived. 
Although the various forms of mechanical intermittent compression of limbs have a 70-
year history of published clinical effectiveness, a complete knowledge of the cause and 
effect process is not yet fully reached. 
One of the first significant commercial devices based on real physiological evidence was 
the ColWil pump developed in the sixties. Many other devices were developed since that 
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early system, with different characteristics and to accommodate different medical 
applications [34]. 
Today in various therapeutic situations the use of an Intermittent Pneumatic Compression 
(IPC) system may be recommended: lymphoedema treatment, deep vein thrombosis 
prevention, management of venous leg ulcers, sport recovery, critical limb ischemia, 
improving of walking distance in patients with intermittent claudication.  
Johansson et al. [35] effected a lymphoedema treatment by an IPC device for the arm 
(Lympa-Press, Liljenberg Medical AB, Malmo, Sweden) employing a 9 compression 
cells, 40-60 mmHg for 2hour/day for two weeks 5days/week, and made a comparison 
with a corresponding manual treatment. They refer no significant difference between the 
two methods, thus demonstrating the possibility to substitute the manual operation with an 
automatic mechanical system. 
Partsch [36] focuses on the importance of using IPC devices in immobile patients, because 
their active venous calf muscle pump does not work. He stresses a lack of specific 
references in literature and lists many parameters being influenced by an IPC (venous 
pressure and velocity, foot/calf venous volume, skin blood flux and many others). He 
highlights the need to understand which IPC system is most suitable for which 
application.  
Another field of use is sports recovery: Wiener et al [37] examined the effect of IPC on 
the legs for the recovery of fatigued Tibial Anterior muscles. After an IPC treatment, the 
muscle fatigue was monitored by surface EMG, showing significant improvement with 
respect to manual passive treatment. For this experience, a LYMPA.WAVE® system was 
used, provided with 7 bladders and operated at maximum pressure of 80 mmHg, used for 
3 minutes after training, performing 2 cycles/min with 21 s inflation and 9 s deflation. 
Similarly, Waller et al [38] made a pilot study aiming to demonstrate that IPC devices 
may be beneficial to the warm-down activities of athletes. They compared two different 
treatments with low pressure (20:15:10 mmHg) and high pressure (70:65:60 mmHg) and 
concluded that “athletes undertaking IPC as part of their training regime should be able to 
increase their training volume with a reduced risk of discomfort and injury”. 
A pair of recent review articles, Comerota [39] and Nelson et al. [40], underlines that in 
various researches an IPC device can be used for the management of advanced chronic 
venous disease, specifically Venous Leg Ulceration. They underline that different devices 
with different pressure levels, duration per day and duration of treatment have been 
performed. Comerota suggests that use of IPC as an adjunct to sustained compression may 
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be the optimal choice for treating patients with VLUs, however a number of questions 
remain, for example the type of compression. Nelson et al. conclude that there is no robust 
evidence that IPC improves ulcer healing when compared with continuous compression 
alone or when added to a standard regimen of compression bandages. There is only some 
generic indication that “fast” IPC therapy has more effectiveness than “slow” therapy. 
Various researchers (Flam et al. [41], Christen et al. [42], Froimson et al. [43]) 
investigated the effectiveness of several commercial IPC devices for the prevention of 
deep vein thrombosis. In general they observed positive results, although each device was 
used with very different settings, as concerns pressure values and cycle times, thus 
indicating a poor knowledge of the relationship between the characteristic and setting of 
the device and the effect on the human. 
Morris et al.[44] tried to evaluate the variety of available systems, with different 
compression techniques and sequences, in order to individuate  appropriate choice criteria 
for each patient. They conclude that rapid inflation, high pressure and graded sequential 
IPC show particular augmentation profiles, but there is no evidence that such features 
improve the prophylactic ability of the device. According to them, the most important 
parameters are the patient compliance and the appropriateness of the site of compression. 
In particular, as regards to the extent of the bladders, they prefer the asymmetric solution, 
with smaller bladder placed only at the back of the limb, rather than bladders extended 
circumferentially around the whole limb. This is because smaller bladders require limited 
size pumps and allow higher operating frequencies.  
A research by Dai et al. [45], oriented to a more quantitative study, defines a method to 
model the deformation of a limb under different cuffs (circumferentially symmetric and 
asymmetric) and to examine the stress distribution within the tissues and the 
corresponding venous blood flow. With a 2D FEM model, they found that asymmetric 
compression would generate larger blood flow velocities and shear stresses than 
circumferentially symmetric compression. However, no consideration is made on dynamic 
effects.  
Malone et al. [46] made a comparison between five IPC devices, two of standard type 
(low pressure: ranging from 40 to 50 mmHg, slow dynamics: 1min cycle, inflation 11-12 
s) and three high pressure (160, 160, 120 mmHg), rapid (22, 22, 30 s cycle, inflation 2 s) 
compression systems. They evaluated the maximal venous velocities at the common 
femoral vein and at the popliteal vein and observed an increase for all devices. The 
comparison between the two kinds of devices showed an increased velocity response to 
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the high-pressure, rapid inflation device. Thus, this research raises a question about the 
need to understand the dynamic behaviour of the device, considering the effect of two 
parameters: pressure level and inflation/deflation time. Actually, these parameters are 
correlated: if inflating time is very short, the contact pressure between leg and device 
could not reach the supply pressure value. 
The need to relate the supply pressure with the real operation pressure (i.e. the contact 
pressure between leg and bladder) as a function of the device characteristics and the work 
cycle timing is an important topic, poorly investigated. 
This crucial point was caught by Lurie et al. [47]. Their study attempted to investigate the 
relationships between the interface pressure produced by IPC devices, the deformation of 
extremity tissues produced by this pressure, and changes in venous blood flow, by use of 
magnetic resonance imaging and duplex ultrasound scans in addition to pressure 
measurement. They used Venaflow® (Aircast Inc, Summit, NJ) (6 s inflating with 0,3 s 
delay between the two chambers, rapid deflating, at 52(distal), 45 (proximal) mmHg and 
WizAir® (MCS Medical Compression Systems Ltd, Or Akiva, Israel) (slow inflation and 
slow deflation at 80 mmHg). They concluded that, while in the past the difference 
between hemodynamic effects produced by various IPC devices has been attributed only 
to the different levels of the air supply pressure, the patterns of pressure actually applied 
to the extremity might be different due to different materials and construction of the 
garments. They also conclude that “further investigation of biomechanical mechanisms of 
IPC is needed to guide the development of better engineering solutions …” 
Summarizing, this review highlights the lack of a general methodology to study and 
develop an IPC device with physical and dynamical characteristics suitable for the 
intended application. 
In particular, the dynamic behaviour of the device in response of the control command is 
practically ignored. 
 
4.3 Commercial IPC devices 
In the market, there are some devices to treat the lymphedema diseases and also to 
improve the cardio circulatory system. These devices work based on the pneumatic 
compression. In the following, some of the devices are described. 
 
 VenaFlow 
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VenaFlow provides intermittent pneumatic compression (IPC) suitable for cases of deep 
vein thrombosis. The device operates using a sequential and graduated compression to 
increase the speed of the blood, reduce stasis and therefore promote the reabsorption of 
body fluids. 
The device consists in electronic device (figure 4.2) , to which are connected , by means 
of a system of pipes , a series of sleeves , inflating and deflating conduct the business 
compressive . In particular, the system can act at three different levels depending on the 
number of sleeves to which are connected: the simplest case with only one foot (figure 4.3 
a), to the case of more extensive than expected to act at the level of the leg (figure 4.3 b), 
or thigh (figure 4.3 c). 
 
 
Figure 4.2. The electronic system and the connecting pipe of the VenaFlow 
 
 
Figure 4.3. The VenaFlow device for acting on the foot (a), calf (b) and limb (c) 
 
In each case the activity of the compression part by a level distal to continue in the most 
proximal. The pressure cycles, consisting in successive inflations/deflations sleeves are 
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automatic and their peaks increase gradually through the first five minutes of operation. 
Moreover, the system is equipped with an alarm system in case of failure or malfunction. 
The normal actual pressure of the device is between 40-50 mmHg. 
The main drawback in the use of the device suggest not to use it for patients with heart 
failure, pulmonary edema , thrombophlebitis, severe atherosclerosis , infection or extreme 
deformity of the leg [48]. 
 
 Bio-Arterial plus 
Bio arterial plus is an Intermittent, Sequential, Pneumatic Compression System that 
sequentially compresses the lower extremity in patients suffering primarily from arterial 
ulcers, ischemia or intermittent claudication. The system is designed to deliver pressures 
of 120 mmHg for two to three treatments per day. It increases arterial blood flow in both 
the popliteal artery and at the tissue level. Through effective compression, resultant 
evacuation of venous blood from the lower limbs enables replacement with substantial 
volumes of oxygenated arterial blood. In the figure 4.4, the Bio-Arterial plus device is 
shown. 
 
 
Figure 4.4. Bio Arterial Plus device 
 
Every cycle takes 20 seconds, so every minute there are three cycles. The inflation takes 4 
seconds ±0.5 s, while the deflation period takes 16 seconds ±0.3 s. It should be noted that 
the delay between the foot and calf is1 second ± 0.5 seconds. This tool is not 
recommended for patients with limb infected, suspected deep venous thrombosis, arterial 
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thrombosis, inflammatory episodes of phlebitis or pulmonary embolism and venous and 
lymphatic return undesirable (such as congestive heart failure) [49]. 
 
 Flexi-Touch system 
The Flexi- touch is a pneumatic compression device, advanced and lightweight, suitable to 
the stimulation of the lymphatic system. This system allows not only the treatment of 
lymphedema from home and chronic edema, but also the prevention of their progression, 
eliminating many of the complications that result from such disorders, including recurrent 
soft tissue infections and chronic fibrosis. 
Unlike traditional compression pumps that press on the affected areas, the system Flexi-
Touch promotes the natural circulation of the fluid through the lymphatic system, to the 
healthy areas of the body. Therefore, its action is different because it proposes the aim of 
exploiting the lymphatic system for the transport of fluids from the areas of the affected 
limb impaired to the healthy regions of the body in which the fluid can be absorbed and 
treated naturally. The mechanism to stimulate the lymphatic system of the Flexi-Touch 
has been clinically proven [50] and has been observed to be more effective than the 
simple pneumatic compression [51, 52]. 
The Flexi-Touch provides a dynamic pressure in a rhythmic manner and gentle on the 
skin, using up to 27 to 32 chambers, through fifteen different programs for the treatment 
of upper and lower body. The program is selectable by using a display, in order to provide 
a customized treatment and efficient. The loading phase lasts only a few seconds for the 
chambers and a full treatment of the leg takes about 45 minutes. In the figure 4.5, the 
Flexi-Touch device is depicted. 
 
 
Figure 4.5. The Flexi-Touch device 
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 Mobility-1 
MOBILITY-1 is the only intermittent pneumatic compression device for lymphedema and 
chronic venous insufficiency (CVI) that allows patient mobility. It applies graduated 
sequential pressure within a fully mobile pneumatic device. Its application is important for 
patients that suffer from various disorders who do not benefit from static compression 
dressings. The main advantages are the full patient mobility with a small fully portable 
compressor, the adaptation to the leg anatomy in real time, the improvement of capillary 
filtration rate, the high patient compliance achievement, the edema reduction and 
prevention, and the promoting of lymphatic drainage with an optimal pressure calibration. 
The application of pressure has two different modes; the first permits the application of 
pressure sequentially from the feet to the top of the leg, while the second mode applies the 
pressure with a sequential and overlapped application of pressure between the bladders 
[53]. In the figure 4.6, the Mobility-1 device is shown. 
 
 
Figure 4.6. The Mobility-1 device 
 
 Lymphastim BTL 
The principle of operation of Lymphastim consists of a pneumatic pressure therapy. The 
applicator with special sleeves and pants in several superimposed. The device makes a 
gentle massage which encourages the natural circulation of the lymph in the human body, 
similar to the manual lymph drainage through the hands of a therapist. 
It is used in various fields such as sports rehabilitation and medicine, and rheumatology 
clinics to Lymphology, in health resorts, hotels and SPA centres of aesthetics. The system 
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allows Lymphastim significant advantages because it is a therapeutic method known and 
clinically approved, with immediately visible results. Moreover, the treatment is well 
received by patients and the body is not unnecessarily burdened with medicines. 
Lymphatic drainage offered by the system allows you to drain the lymph within the 
lymphatic vessels, causing the natural flow from the peripheral parts of the body. Hence it 
reduces swelling and pain caused by the excessive amount of lymph and metabolites in 
the limbs. Lymphastim also helps the healing and regeneration of muscle tissue, 
increasing the tone and elasticity of the skin. 
It is a 12-channel device with easy-to- use user interface with colour touch screen 5.7 ". 
BTL has encyclopedia with medical and aesthetic protocols, sequences, pre-set programs, 
internal memory to store up to 100 user-defined programs (thus allowing for specific 
treatments and custom). It can set the continuous pressure from 20-160 mmHg with 
adjustment of the gradient, and pressure control separate for each chamber (their operating 
activities is shown on the display). 
It is a system easy to wear, the connection of the applicators is simple and is equipped 
with a compressor reliable and silent [54]. In the figure 4.7, the Lymphastim BTL device 
is depicted. 
 
 
Figure 4.7. The Lymphastim BTL device; the compressor and sleeves (a), the device worn by a patient 
(b) 
 
 BALLANCER 
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The BALLANCER is a device designed for aesthetic applications such as body care, 
slimming and cellulite reduction. The lymphatic drainage massage produced by the 
system, is used for the treatment before and after liposuction, to reduce edema post- 
surgery and the swelling for the treatment LPG cellulite. The BALLANCER mimics the 
movement of a manual massage giving the feeling of two hands which move 
simultaneously. In figure 4.8, the BALLANCER device is depicted. 
 
 
Figure 4.8. The compressor and the body of the BALLANCER device 
 
It is therefore a specific device for an effective massage aesthetic tire with applications not 
only at the level of the lower limbs but also superior, simply connect the device with the 
corresponding supplement. The technical characteristics of the compressor allow: a 
pressure adjustment from 20 to 80 mmHg, a peristaltic cycle of 35 minutes. The size of 
the compressor is reduced (14.5 x 30.5 x 38.5 cm) with a weight of only 5.1 kg, this 
allows ease of transport. 
There are some cases in which the using of the device are not recommended; in presence 
of pain, in the case of atherosclerosis or vascular ischemia, heart failure, or in case of 
suspected presence of deep vein thrombosis, thrombophlebitis, gangrene, dermatitis, 
infected ulcers or inflammatory processes [55]. 
 
 LymphaWaveTM 301 
This device is particularly indicated for the treatment of lymphatic problems, suffering 
with localized lymphedema and venous ulcers. The cycle of peristaltic LymphaWaveTM 
promotes lymphatic and venous return, making it particularly suitable for post-traumatic 
edema, edema of venous origin, ulcers in the postoperative course of perforator ligation or 
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stripping of the Saphenous vein in the post- mastectomy lymphedema with scars. In figure 
4.9, the LymphaWaveTM device is depicted. 
 
 
Figure 4.9. The LymphaWaveTM device 
 
The pressure can be adjusted from 20 to 80 mmHg, according to medical indication, 
making the device safe even for a home use; specifically for the treatment of lymphatic 
problems. 
Technical characteristics of the compressor include a pressure adjustment from 20 to 80 
mmHg, a peristaltic cycle of 30 s (4s break), with a maximum time of use around 120'. 
It is not recommended to use in the presence of pain, in the case of atherosclerosis or 
vascular ischemia, heart failure, gangrene, dermatitis, ulcers and infected in the presence 
of inflammatory processes [56]. 
 
 Aviafit 
Aviafit is a small and portable intermittent pneumatic compression device, designed for 
all those who live in a situation of limited mobility; at home, in the office or on the road. 
The device is designed to be used by surgical patients from the beginning of the surgery, 
during hospitalization, up to when patients are no longer at risk of thrombosis. Among 
those most at risk of thrombosis can cite smokers, overweight people, and pregnant 
women, at risk of abortion or undergo hormone treatments. 
The portability allows the treatment for more than 20 hours a day continuously, the 
system is a safe alternative (it has no known side effects) and effective alternative to 
anticoagulant drugs. Aviafit clinically tested and uses to prevent stagnation of blood clots 
in the blood, stimulates the circulation in the legs and then prevents the onset of deep vein 
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thrombosis and helps to reduce swelling in the legs and ankles. The set includes 2 units by 
means of straps to tie around the two legs (one leg) at the level of the calf muscle (over or 
under clothing). Figure 4.10 shows the Aviafit device.  
 
 
Figure 4.10. The Aviafit device 
 
In several clinical studies published, Aviafit has shown that it is able to increase the peak 
velocity of the flow in the veins. It was also verified that it is able to provide the same 
hemodynamic benefits of conventional intermittent pneumatic compression devices, 
highlighting the benefits for the prophylaxis of thromboembolism, increased compliance 
in rehabilitation and home care. The measured increase is equivalent, and in some cases 
superior, to that measured using compression devices stationary [57]. 
 
4.4 The designed IPC device 
In this study based on the previous IPC devices and their deficiency, we decided to design 
the prototype to cover all philological and mechanical aspects. In addition, the prototype 
must consider the convenient and the conditions of the patients.  
Two IPC prototypes were designed in the laboratory of the Mechanical engineering 
department of PoliTo, that in the following sections those are described. 
 
4.4.1 Prototype 1 
This prototype was the first device that made in the laboratory. It includes 6 bladders, a 
rigid body to support the bladder, the electrical control system, and the pneumatic circuit. 
In the figure 4.11, the prototype 1 is depicted. 
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Figure 4.11. The first prototype made in the laboratory 
 
The prototype was tested on the volunteer persons with cooperation of the Caliari 
University and the positive effects on the cardiovascular system were reported.  
To characterize this device we faced several problems about its rigid body. Due to the 
rigid body, the adaptability of the device on the leg and using of the maximum air energy 
exerted to the leg ignored. Moreover, it causes the gap between the bladder and the skin 
and this value may be different in the persons and it depends on the shape of the leg. 
Therefore, the characterization of the device in presence of this undetermined value is not 
so accurate. 
Another problem was the displacement of the device. To move the device and transport of 
that, the weight of the rigid body makes some difficulties. So, we decided to optimize the 
prototype and making a new one to remove the uncertainties and more convenient in the 
displacing. 
 
4.4.2 Prototype 2 
The second prototype has the objective to overcome the limitations of the previous one, 
especially for what concerns the problems of fit and adaptability to the shape and 
dimension of the limbs, in order to improve the effectiveness of the air energy to the 
muscle at the level of interface. In this prototype, instead of the rigid body, the flexible 
and inextensible tissue is used to support the bladders. The inextensibility of the tissue 
causes the expansion energy of the bladders only affect on the limb size. And the 
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flexibility of the tissue allows to the device to adapt as much as possible to the anatomy of 
the limb. In the figure 4.12, the second prototype is shown. 
 
 
Figure 4.12. The second prototype made in the laboratory 
 
Also in the figure 4.13, the whole system used in this study is depicted. 
 
 
Figure 4.13. The whole system of the IPC device 
 
In the system, the pressure source or air compressor 1, compresses the air until the given 
value of the pressure and by using the elastic pneumatic pipe the compressed air transit to 
the micro-electric valves 4. There are 6 micro-electro valves to connect each bladder to 
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the pressure source in inflating or to ambient in deflating. The signal for opening and 
closing of the valves, come from the PLC 2, which is supplied by electrical source 3. 
In the following each components of the system is described more. 
 
4.4.2.1 The bladders 
In the IPC devices, the mechanical action is provided by pneumatic energy through the 
bladders. Bladders are sealed cells which are very strategic element in such devices. In 
order to optimize the performance, it is convenient that the air energy is directed as much 
as possible towards the biological tissues of the limb, rather than used to deform the 
materials of the device structure. To this aim, the bladders should be able to expand with 
limited or null stretching of the wall and this can be achieved both by proper shaping of 
the cell and adopting a material which should be compliant but, of course, air-tight. In 
addition, the number of the bladders and its area are so important to cover the muscle s of 
the leg and foot.  
In our IPC device, the bladders are made of Windtex® tissue and there are 5 bladders for 
the leg and 1 for the foot. The bladders cover all regions of the leg and foot. Also the 
bladders are numerated as 1-6 from foot to leg. In figure 4.14, the bladders of the IPC 
device are shown. 
 
 
Figure 4.14. The bladders of the foot (a) and the leg (b) 
 
To optimize the situation in deformation of the bladders towards the leg and cover the 
whole of the leg, we used several plans for the area of the bladders and how they should 
attach to the shell. The best was determined when the bladders are rectangular with 
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different in width and same height equal 5 cm. To attach the bladders to the shell the 
bladders fold in the longitudinal direction as 1 cm on the edge and are glued to the shell. 
In this case to cover the region of the leg the bladders have overlapping with together 
about 0.5 cm. For the foot, the bladder is rectangular with the size 16.5*12 cm to cover the 
whole muscle of the foot for normal person. In the figure 4.15 the plan of the bladders are 
shown. 
 
 
Figure 4.15. The plan of the foot bladder (a) and the leg bladders (b) 
 
4.4.2.2 Programmable Logic Control (PLC) 
A programmable logic controller (PLC) is a programmable microprocessor-based 
embedded designed to perform programming and control of temporal sequential 
processes. It has the facility for extensive input/output (I/O) arrangements through the 
implementation of specific functions such as logic, sequencing, timing, counting, and 
arithmetic. PLCs are categorized by the number and type of I/O ports they provide and by 
their I/O scan rate. The used PLC in this IPC device belongs to the SIEMENS company 
and its model is LOGO 24RC. The PLC is used for the electrical commandment of the 12 
pneumatic valves (six for each leg). This commandment is proceeding while sending 
diverse signals configured with different characteristics for the independent opening and 
closing of the valves. The differences between the signals are basically the duration of the 
period, the step size, the diphase or overlapping between the six valves, and the breaks 
inside the periods. The numeration of the valves is ranked in increasing order from bottom 
to top. Accordingly, the first bladder corresponds to the first pneumatic valve, so that the 
first bladder is in contact to the foot. 
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The programs have been used for the opening and closing the valves can be defined as 
below: 
 
 Program A 
This program is very fast and each bladder is open for 0.5 s. Inflating of the bladders in 
this program are without any overlapping and the cycle for one leg takes 3 s and for two 
legs takes 6 s.  In the figure 4.16 the sequence diagram of this program is shown. 
 
 
Figure 4.16. The sequence diagram of the program A for one leg 
 
 Program B 
The program B has been proposed in two versions, with B1 cycle duration T = 4 s, and 
B2, which is the same cycle but slower T = 7 s. In the first case, each valve remains open 
for a period of 0.75 s, and the valves are opened in sequence one after the other with an 
overlap of 0.25 s. When the last valve is closed, the system remains stationary for 0.25 s 
before starting the next cycle. 
Regarding the program B2, the relationships between the valves are the same but in 
double time. So each valve remains open for a period of 1.5 s and the valves are opened in 
sequence one after the other with an overlap of 0.5 s. When the last valve is closed, the 
system remains stationary for 0.5 s before starting the cycle on the other leg. The 
complete cycle for two legs takes 14 s in this program. In figure 4.17 the sequence 
diagram of the program B2 is depicted.  
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Figure 4.17. The sequence diagram of the program B2 for one leg 
 
 Program C 
The program C is characterized by a cycle of 6 s. The activation of the valves is 
superimposed through the cycle and those are activated progressively from the foot to the 
leg and remain active until the end of the cycle. 
Therefore the first valve (V1) is activated at the beginning of the cycle and is kept open 
for 6 s, one second after the second valve is opened while keeping such a state for a 
duration of 5 s, and so in a second sequence after another, the other valves are activated 
until the last which remains open only for a time of 1 s. At this point after 6 s, the valves 
are closed together for one second and after that the cycle is started for the other leg. In 
this program a complete cycle for two legs takes 14 s. In the figure 4.18 the sequence 
diagram of this program is shown. 
 
 
Figure 4.18. The sequence diagram of program C for one leg 
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 Program A_ap3 
The program A_ap3 is characterized by a total cycle time of 36 s (18 s per leg). Each 
valve is opened in sequence (then no overlap), one after the other, starting from the valve 
controlling the bladder to the foot and ending with the valve to the knee. The time in 
which the valve remains open is the same for all and that is 3 s. Once the cycle on one leg, 
starts on the same loop on the other. Figure 4.19 represents the signals supplied to the 
individual legs. 
 
 
 
Figure 4.19. The sequence diagram of program A_ap3 for one leg 
 
 Program B_ap3 
The program B_ap3 is characterized by a total duration of 21 s (10.5 s per leg). Each 
valve is opened in sequence, at a distance of 1.5 if it remains open for a period of 3 s. At 
the end of the cycle starts again on one leg in a similar manner on the other. The 
configuration of the signals in time for the individual leg is represented in Figure 4.20. 
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Figure 4.20. The sequence diagram of program B_ap3 for one leg 
 
 Program B_new 
The program B_new is characterized by a total duration of 13 s (6.5 s per leg). Each valve 
is opened one after the other at a distance of 0.5 if it remains open for 4 s. At the end of 
the cycle starts again on one leg in a similar manner on the other. The configuration of the 
signals in time for the individual leg is shown in Figure 4.21. 
 
 
Figure 4.21. The sequence diagram of program B_new for one leg 
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 Program C5 
The program C5 is characterized by a total duration of 24 s (12 s per leg). Each valve is 
opened one after the other (starting from the valve to the foot and ending with the valve at 
the knee) at a distance of 1, if they remain active for different times. In particular, the 
valve V1 is open for 6 s, the valve V2 for 5 s and from the valve 3 (ie V3, V4, V5, V6) 
remain active for 4 s. After the closure of all valves on the first leg there is a pause of 3 s, 
during which all the valves are closed before restarting the cycle on the other leg. The 
configuration of the signals in time for the individual leg is represented in Figure 4.22. 
 
 
Figure 4.22. The sequence diagram of program C5 for one leg 
 
4.4.2.3 Micro electro valves 
The pneumatic valves are an essential component of the device for the control of pressure, 
flow rate and direction of the air. The air must be controlled in order to inflate and deflate 
successfully the bladders of the device.  
The six pneumatic valves used in the device are solenoid 3/2 way valves. In the figure 
4.23, the pneumatic valves are shown. 
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Figure 4.23. The pneumatic valves used in the device 
 
A solenoid valve has two main parts: the solenoid and the valve. It is an 
electromechanically operating valve which is controlled by an electric current through a 
solenoid. The solenoid converts electrical energy into mechanical energy which, in turn, 
opens or closes the valve mechanically. 
In the case of a three-port valve, the outflow is switched between the two outlet ports 
(exhausted port and the port for the bladder). 
 
4.5 Experimental physiological test of the IPC device  
The second prototype was tested experimentally on 19 voluntary subjects in the laboratory 
of Sports Medicine at the Cagliari University and by Echocardiography ECG and 
Impedance Cardiometry devices the most important parameters of the cardiovascular 
system were studied. 
 
4.5.1 Study population 
A group of 19 male healthy subjects aged between 20 and 35 years (Height: 1.74 ± 0.08 
m; Weight: 66.2 ± 8.5 kg) were recruited, none had any history of cardiac or respiratory 
disease or was taking any medication at the time of the study. Each volunteer gave written 
consent to take part in this study after they had been given detailed information on the 
procedures and risks. Subjects were asked to refrain from caffeine, alcohol and physical 
activity for 12 h, and eating for 3 h, prior to the inflation test. All experiments were 
carried out in a temperature-controlled room (room temperature set at 22º C, relative 
humidity between 40-50%). Before, during and after each test routine cardiovascular 
parameters were assessed. The study was performed according to the Declaration of 
Helsinki and was approved by the local ethics committee.  
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4.5.2 Inflating tests design 
Before monitoring the cardiovascular response during the activation of the device, each 
subject was monitored at rest for 3 min to collect baseline values. Then, the IPC device 
was placed to the subject to collect the data (Figure 4.24). Once the preparation was 
completed, all volunteers underwent a compression-relaxation protocol. 
 
 
Figure 4.24. Placement of the device and equipments for the experimental tests 
 
The device operating protocol adopted is the same as program B_ap3, the one reported in 
figure 4.20 in sequence and inflating time. Only the difference is in delay of 3 s between 
the two boots; thus the entire cycle including both boots was 27 s lasting. The inflating 
relative pressure reached the maximum value of 0.3 bar. On each thigh an elastic 
containment stocking was worn to reduce the venous distension coming from the increase 
of blood flow during the mechanical actuation. 
 
4.5.3 Hemodynamic assessment 
Hemodynamic variables were monitored and recorded beat-to-beat by means of an 
impedance cardiography device (NCCOM 3, BoMed Inc., Irvine, CA) which allows a 
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continuous non-invasive transthoracic electrical bioimpedance (TEB) assessment 
throughout all the phases of the protocol [58]. The scheme of using the device and how to 
assess the hemodynamic variables is sown in figure 4.25. 
 
 
Figure 4.25. Electrical Schema of an impedance cardiography device 
 
According to the figure 4.25, an electrical current generator (G) was connected to the 
subjects’ thorax by two pairs of disposable ECG electrodes (green snap fastener): the one 
pair cervical and the other thoracic, in such a way to inject into the thorax a constant, 
alternating current (2mA, 70kHz).  Other two pairs of electrodes (red snap fastener) were 
sensing electrodes and were placed respectively 5 cm below those cervical and 5cm above 
those thoracic injecting current. Both pair sensing electrodes were tie up the amplifier 
section (A) of the impedance device, from which analogical signals of thoracic electrical 
bioimpedance Z0 (Ohm) were detected.  
Totally, the impedance device was connected to the subject by eight electrodes: two pairs 
were thoracic and cervical electrodes to inject a constant current (2mA, 70kHz), whereas 
two other pairs were sensing electrodes placed above the cervical and below the thoracic 
pairs [59]. The electrical signal was recorded by a digital chart recorder (AD Instruments, 
PowerLab 8sp, Castle Hill, Australia) [60].   
Analog traces of TEB, i.e. the thoracic impedance value (Ω) results from the Ohm law or 
from ratio between applied voltage difference to the thorax by the alternate current (G in 
figure 4.25) and the circulating electrical current into thorax collected by an electronic 
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amplifier (A in figure 4.25). Beat-to-beat values of TEB at the end of cardiac diastole (Z0) 
were acquired and Z0 was utilized as an inverse index of LVEDV [61].   
The rationale for this choice is shortly presented here so on. Considering the electrical 
resistors which all together constitute an electrically equivalent model of the thorax, most 
of they are of solid consistence (muscles, bones, cartilages, vessels, connective tissue of 
lungs) which, for this, do not vary their mass suddenly. On the contrary, lung air content 
and intrathoracic liquids content are subjected to cyclical changes. So, changes in 
equivalent electrical impedance of the thorax, i.e. Z0, refer about a like sinusoidal 
oscillation which shows two harmonics:  the main one corresponding to breathing phases 
and the secondary one, with a lesser amplitude, corresponding to cardiac cycle phases. By 
utilizing a common electronic band-pass filter the main respiratory harmonic of Z0 can be 
excluded and, in this way, observed changes in Z0 only depends on changes in 
intrathoracic liquids volume. These in turn depend on both blood volume into heart and 
thoracic vessel and on extra-vessel water volume. It is expected that, in a healthy subject, 
extra-vessel water volume does not change significantly, thus Z0 ought to depend 
essentially by beat-to-beat variations of thoracic blood volume which reach its relative 
peak when ventricles get to end diastolic volume. Since blood is a more conducting 
electrical current tissue, an increase in end diastolic volume induces a corresponding 
reduction in Z0.  
 
4.5.4 Results 
Figure 4.26 shows a typical experimental session. In each subject Z0 values were assessed 
just before the test beginning (Z0-basal) and just at the end of the test (Z0-test). During 
tests ECG traces were assessed. Assessed values of Z0-basal were compared with Z0-test 
values by the Students’t-test for paired samples and a value of P<0.05 was considered as 
significant. 
As shown by the columns height in the graphs of Figure 4.26, mean values ± SEM of Z0-
basal and Z0-test were 26.73 ± 3.88 Ohm and 26.38 ± 3.88 Ohm respectively. Students’t 
for paired samples was: - 4.62 with P < 0.0002. So, the mean reduction of Z0-test values 
with respect to that of Z0-basal values was highly significant. 
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Figure 4.26. The value of Z0 before the test (Z0-basal) and after the test (Z0-test) 
 
Test induced changes in Thoracic electrical impedance. Columns represent mean values of 
the thoracic electrical impedance respectively before legs compression session (Z0-basal) 
and just at the end of the compression session (Z0-test). Vertical bar in each column 
represent SEM. *P < 0.0002 with respect to the Z0-basal mean value. 
 
4.5.5 Discussion 
The mechatronic device here tested showed good chances to substitute physiological 
features in producing sufficient venous return for avoid LVEDV loss in bed-rest, 
endurance athletes. In fact, a good feedback for this possibility arose from the observed 
statically significant reduction in Z0 just after a leg compression test which lasted less 
than 30 s.  
Several previous studies support, both in animal and in humans, reciprocal and consistent 
relationship between Z0 and LVEDV. Luepker et al [62], in anesthetized dogs in which 
the thoracic extra-vessel fluid was maintained at a constant, found that changes in central 
blood volume (CBV) were highly correlated with Z0 changes (r = -0,978). They also 
calculated the following linear regression equation: [Z0 = 101,3 – 0,68 (CVB)] in which it 
appear that each unitary increase in CBV induced a Z0 decrease of about an half.   
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Now considering humans, Okutani et al. [63], while applying head up tilt manoeuvres in 
healthy subjects, showed that when head up was reached the Z0 rose up to +9.5% than the 
pre-test value. Moreover, legs venous occlusion while recovering supine position showed 
that Z0 fall but its final value was higher than that recovered without occlusion. Since in 
these subjects legs venous occlusion reduced LVEDV, the fact that Z0 correspondingly 
did not recover pre-test, lower values demonstrates that it is inversely correlated to a 
reached LVEDV. This latter conclusion is also supported by the observation that, passing 
from standing to supine position, a group of healthy subjects showed ultrasonographic 
images of left ventricle which indicates a LVEDV increase of about 24% while Z0 fall of 
about 7% or a reduction of about one third of  Z0 at each unitary increase in ventricle 
volume (personal observation). 
Recently [64] it has been found that during passive recovery following repeated bouts of 
supramaximal exercise at a cycle ergometer, Z0 progressively increased during passive 
recovery  (+1.6 ± 0.4 Ω at the 10th minute of recovery) since the absence of pedalling 
after a strenuous cycling exercise may result in a serious blood pooling into leg veins [65]. 
On the contrary, when in the same experiment an active recovery was done Z0 did not 
increase (+0.05 ± 0.3 Ω at corresponding time points of passive recovery period), and the 
difference between these two kinds of exercise recovery was statistically significant (P < 
0.05). 
Our actual results showed that the applied compression protocol induced a Z0 reduction of 
about -1.3% with respect to the pre-test value. Considering that: i) in a previous study [66] 
in which distance runners  performed a cycle ergometer incremental exercise, their highest 
reduction in Z0 (-4.5%) was reached when workload was 50% of that maximum; ii) in 
another study [67]  a group of endurance athletes who also performed  an upright bicycle 
test at about 50% of maximum workload (their heart beat was 130/min) the LVEDV 
showed its maximum increase of 33 mL which was +23% of corresponding rest value; iii) 
speculating now with a proportional approach it can be deduced that, if -4.5% Z0 (from 
reference 30) ought to correspond to+23%  LVEDV (from [67]) then -1.3% Z0 (in the 
present research) ought to correspond to an extrapolated LVEDV increase of about 10%.  
In addition, increasing of the LVEDV about 10% causes the cardiac output CO and stroke 
volume SV increase about 9.4% and 16% respectively [68,69]. 
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5. MATHEMATICAL MODEL OF THE IPC 
DEVICE  
 
Mathematical modelling of a system means describing the system by using the 
mathematical concepts and formulations. The purpose of the modelling is to predict the 
behaviour of the system in static or dynamic situation and determine the effectiveness of 
the different parameter on the performance of the system. The mathematical model 
includes the linear or nonlinear differential equations, operators such as algebraic 
operators, and a sort of variables and uncertainties. In other words, the mathematical 
model can connect the input and the output of a system by mathematical equations.  
The reliability of results depends on the number of variables and interactions considered, 
as well as the presence or absence of factors of uncertainty which may affect the operation 
of the system and the initial data. As much as the variables and physical parameters 
choose accurately, the results of the mathematical model are close to the experimental 
one. Therefore, to have the reliable and accurate mathematical model, it is necessary to 
understand the variables and their relationships as well as determining the physical 
parameters of the system. 
An accurate mathematical model of the IPC device is a fundamental tool for 
understanding the physical behaviour and setting all structural and functional parameters. 
The model must consider all physiological and mechanical principles which have to be 
harmonized for the expected therapeutic methodology. 
It is supposed that the basic requirement for a given therapeutic protocol is the application 
of a rhythmic pressure to a limb; the pressure must be automatically controlled as regards 
in particular the frequency and the maximum/minimum levels. 
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A conceptual block diagram of the system may consider a single module with one bladder 
supplied by one pneumatic valve, as depicted in figure 5.1. The bladder and the limb 
together form the so called “Human-Machine System”. 
 
 
Figure 5.1. Conceptual block diagram of the system 
 
The micro electric valve is supplied by a given pressure source PS and is commanded by a 
digital on-off signal; the air flow Q from the valve inflates the bladder, producing a 
variation of the internal air pressure Pi and of the contact pressure PC on the limb; this 
latter is then deformed by an amount x which in turn affects the volume of the bladder. 
The bladder pressure Pi also influences the mass flow rate Q. 
The contact pressure PC is the physical quantity which must be controlled. 
To model the whole of the system, it is required to characterize all subsystems and 
determine their parameters. In the following, the modelling procedure is described.  
 
5.1 Modeling of the pneumatic circuit subsystem 
The pneumatic circuit subsystem for one bladder comprises a 3-port electro-pneumatic 
mini-valve, connected to a supply source on one side and to the bladder on the other side. 
The switching of the valve between its two operating conditions connects in turn the 
bladder either to the supply source or to the exhaust.  
To model the pneumatic system it is necessary to express the air mass flow rate through 
the valve as a function of the supply and bladder pressures, and of the operating 
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conditions. This can be done by using the formulation defined by the ISO 6358 Standard 
[70], which considers the two possible conditions of sonic and subsonic flow. The figure 
5.2 shows the typical shape of a valve flow curve for fixed upstream pressure P1 and 
variable downstream pressure P2. The symbol QC indicates the critical flow rate. One 
must consider that, depending on the valve condition, the bladder inner pressure Pi can 
correspond either to the downstream pressure P2 (when the bladder is inflated and the 
upstream pressure is the supply pressure PS) or to the upstream pressure (when the bladder 
is deflated and the downstream pressure is the ambient pressure PA). 
 
 
Figure 5.2. The flow curve of a pneumatic valve 
 
According to the above Standard, the valve flow rate can be analytically expressed by 
interpolating functions: 
 
 
            
   
   
 
 
                         for subsonic flow 
                       for sonic flow 
(5-1) 
 
Where: C is the valve conductance, H is a corrective factor depending on the inlet air 
temperature (H =1 at standard conditions, with P1=1.013 bar and T=273 K); r=P2/P1 is the 
actual pressure ratio; b is the critical pressure ratio (when P2 reaches the critical value 
P2CR=b·P1). 
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The valve coefficients C and b can be evaluated by the experimental characterizing of the 
valve.  
 
5.1.1 Characterizing of the pneumatic micro-electro valve 
Characterizing a valve can be done by determining its flow curve. In this case, since the 
valve use for the inflating and deflating, characterizing the valve can be done in the two 
conditions. In the following the coefficients C and b for both inflating and deflating will 
be obtained experimentally. 
 
 Inflating condition 
The schematic of the system to obtain the flow curve of the valve in this condition shows 
in figure 5.3. 
 
 
Figure 5.3. Schematic of the system to obtain the flow curve in inflation condition 
 
 At the first the flow regulator is close and flow meter indicates no flow rate.  So the 
upstream and downstream pressure of the valve are equals (P1=P2). By progressively 
opening the flow regulator, the pressure P2 will decrease and the flow rate up to a critical 
point at which the flow rate becomes constant even if the flow regulator is opened further. 
This critical corresponds to the sonic condition of the flow. Once the flow regulator is 
completely open, the maximum flow rate is constant from critical point and the value of 
downstream pressure is 0, P2 = 0. 
According to equation 5-1, The valve conductance (C) is the ratio between the maximum 
flow rate (Qc) and absolute inlet pressure (P1) under sonic flow condition at a temperature 
of 20°C. In addition, critical pressure ratio (b) is the ratio between the output absolute 
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pressure (P2) and the inlet absolute pressure (P1) at which the flow becomes sonic. (b = 
   
  
) 
To characterize the valve and determining valve conductance (C) and critical pressure 
ratio (b) in the inflating condition, the experimental tests (as it is shown in Figure 5.3) 
have been done in three different inlet pressures and their flow curves are shown in figure 
5.4.  
 
 
Figure 5.4. Experimental flow curves of the valve for three inlet pressure 
 
According to the figure 5.4, the valve conductance and critical pressure ratio can be 
obtained for each flow curve and the mean value of them can be considered as properties 
of the valve. So, the parameters C and b for the valve in the inflating condition are: 
 
C = 50 (
  
     
)  
b = 0.02 
 
Once the parameters b and C are obtained, it is used to develop the correspondent 
equation 5-1, in order to calculate the flow rate Q. Moreover the pressure ratio r can be 
obtained by the ratio between the downstream pressure P2 and the upstream pressure P1. 
 
 Deflating condition 
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In this condition, the schematic of the system which is used to characterize the valve is 
shown in figure 5-5. 
 
 
 
Figure 5.5. Schematic of the system to obtain the flow curve in deflation condition 
 
The process of obtaining b and C in the deflating condition is the same as inflating 
condition. The coefficients in this condition are calculated as: 
 
C = 50 (
  
     
)  
b = 0.2 
 
According to the value of the C and b in both inflating and deflating condition, it can be 
deduced that the conductance C is independent of the valve operation. 
By calculating the coefficients C and b, and substituting in the equation 5-1 for subsonic 
condition, the flow rate Q can be obtained. Also the mass flow rate can be obtained by 
multiplying the flow rate to the density of the air. 
 
 qm = Q * ρ (5-2) 
 
Where ρ is the density of the air in the normal conditions. 
After determining the all parameters of the pneumatic circuit system, it is possible to 
implement the mathematical model in the SIMULINK ambient. Figure 5.6 shows the 
system is implemented in the SIMULINK ambient.  
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Figure 5.6. The implemented pneumatic circuit system in SIMULINK 
 
 5.2 Modeling of the human-machine subsystem 
The Human-Machine System represents the interaction between the bladder and the limb. 
A possible schematization of the system is shown in figure 5.7. The bladder is considered 
as a compliant closed volume supported by the device shell; the limb is schematized as a 
compliant body (the muscle) supported by the bone.  
 
 
Figure 5.7. Scheme of the human-machine subsystem 
 
The main mechanical characteristics are the transversal muscular stiffness KM and the 
bladder wall stiffness KB. Pi is the pressure inside the bladder; PC is the contact pressure 
between bladder and limb. x and y represent respectively the deformation of limb and 
bladder under the effect of the pressure. The actual height of the bladder is indicated as h, 
whose initial value (no pressure in bladder) is h0; d represents the actual distance (gap) 
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between the shell and the limb, with initial value d0; in case of skin-bladder contact, h=d. 
The initial values h0 and d0 represent the “rest condition” of bladder and limb respectively, 
i.e. when a null pressure is acting on the system. 
The physical behaviour of the bladder can be described by the scheme of figure 5.8. The 
internal pressure Pi depends on the mass flow rate Q coming from the valve and on the 
deformation y of the bladder; the contact pressure PC on the limb depends on the inner 
pressure Pi and on the deformation y. The relationship between the bladder deformation y 
and the limb deformation x can be determined by a discussion of the contact condition. 
 
 
Figure 5.8. Scheme of physical behaviour of the bladder 
 
The flow continuity equation for the bladder can be written as: 
 
 
  
 
  
   
  
 
   
  
  
  
 (5-3) 
 
Where Q is the air mass flow rate entering the bladder, Pi is the absolute air pressure, W is 
the actual volume of the bladder, R is the air constant, T is the absolute temperature, A is 
the bladder-limb contact area. 
The volume of the bladder can be expressed as: 
 
           (5-4) 
 
The equation (5-3) is nonlinear; its integration allows the calculation of the absolute 
bladder pressure Pi but requires the knowledge of the bladder deformation y. 
In the following, a capital letter P indicates an absolute pressure, while pressures relative 
to ambient will be indicated by a small p. 
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The difference between pi and pC depends on the stiffness of the bladder wall and is a 
function of its expansion, as expressed by the following equation: 
 
           (5-5) 
 
To evaluate the bladder stiffness KB it is worth mentioning that, because of the bladder 
material, the elastic term          is existing only when the bladder wall is stretched. 
The variation of the bladder elastic force with respect to the bladder height can be 
experimentally valued by inflating the bladder in no-constraint condition, as represented 
in figure 5.9.  
 
 
Figure 5.9. Evaluation of the bladder elastic stiffness 
 
In this way, a variation in the inner pressure determines variation of the height, according 
to a given trend; this function can be approximated by two straight lines, so individuating 
a “height at rest” h0, reached at an almost null inner pressure, and an “elastic range” in 
which the bladder wall is stretched and the height increases with the pressure. Therefore, 
the equation (5-5) can be split to consider the full range of the bladder expansion: 
 
                                                         (5-6) 
Mathematical model of the IPC device                                                                              56 
 
 
 
                                      
 
The actual value of KB depends on the wall material and also on the shape and dimension 
of the bladder. By way of example, a rectangular bladder of 5 by 30 cm sides, made of 
Windtex®, presents an average            of about 5·10
5
 Pa/m. 
According to the figure 5.7, from the muscle side, it is possible to write: 
 
        (5-7) 
 
The determination of the transversal muscular stiffness KM is a very crucial point. The 
value of this parameter is subjective and depends on the muscular condition of the limb. 
No information about that is available in literature and very few researchers, like Dai et al. 
[45] tried to experimentally measure this characteristic. A possible way to determine it is 
described by the scheme of figure 5.10.  
 
 
Figure 5.10. Scheme of experimental setup to evaluate the transversal muscular stiffness 
 
In such a device, a tension T is applied to a strip 3 wrapped around the limb 4; the tension 
is regulated by a screw device 1 and measured by a load cell 2. In the figure 5.11, the 3-D 
scheme of the device and how applying to the leg is shown. 
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Figure 5.11. The 3-D scheme of the device is used to measure transversal muscle stiffness 
 
When the tension T is applied, the limb deforms by a given amount, depending on its 
muscular stiffness. The applied contact pressure can be calculated considering the 
muscular tissue as a fluid mass, as depicted in figure 5.12, by the following equation: 
 
 
   
 
   
 (5-8) 
 
 
Figure 5.12. The string applies contact pressure to limb by tension T 
 
Where r is the radius of the limb and l is the height of the strip. The muscular stiffness is 
measured and expressed as: 
 
 
   
   
  
 (5-9) 
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Experimental tests on three different subjects provided values of muscular stiffness that in 
the following is described. 
 
5.2.1 Experimental measurement of the transversal muscle stiffness KM 
The experiments were repeated by three members of our group, each of them with 
different ergonomic conditions. During the process, some parameters were obtained: the 
length of the circumference described by the strip around the leg (L), the initial distance of 
the movable piece with respect to a reference point, the displacement of the movable piece 
measured with the bearing micrometre (ΔD), the tension in the sensor thread measured 
with the force sensor (T), and the height of the strip (l). According to the physical 
principle described before, the muscular stiffness can be calculated by equation (5-9). 
The parameter Δr is calculated with the difference between the initial radius of the 
circumference described by the strip around the leg (r0) and the value of the current radius 
(r). 
 
 Δr = r0 – r (5-10) 
 
The current radius of the circumference (r) is calculated as the difference between the 
initial length of the circumference (L0) and the displacement of the movable piece (ΔD), 
divided by twice the value of pi (π). 
 
 
r = 
 0 -  ∆D
2 π
 (5-11) 
 
And the pressure is obtained by: 
 
 p = 
T
r .  l
 (5-12) 
 
As a result, the pressure will be calculated as the coefficient between the tension measured 
in the force sensor, and the product of two factors: the current radius of the circumference 
described by the strip around the leg (r), and the height of the strip (l). 
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The measurements were repeated between two and three times for each member and the 
results are shown in figure 5.13. 
  
 
Figure 5.13. Pressure as a function of ∆r corresponding to 3 members 
 
According to the figure 5.13, the value of the transversal stiffness of the muscle can be in 
the range 3*10
6
 - 7*10
6
 (Pa/m). 
 
5.2.2 Characterizing the contact between bladder and limb 
The integration of equation (5-3) requires expressing the bladder deformation y as a 
function of pressure Pi. To do that it is necessary to detect if there is contact between 
bladder and limb. 
The existence of the contact can be determined by calculating and comparing the values of 
the bladder height h=h0+y and the total gap d=d0+x (with reference to figure 5-7). 
Therefore to characterize the contact, it can be divided into two conditions: contact and 
without contact. 
 
 Without contact 
In this case, there is no contact between the bladder and the limb. It means, the gap 
between the shell and the limb is more than the total height of the bladder after air 
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supplying (h<d). Therefore, the radial deformation of the limb is zero (x=0). In the figure 
5.14, the without contact condition is depicted. 
 
 
Figure 5.14. The without contact condition - The gap between shell 2 and the limb 3 is more than the 
height of the bladder 1 after air supplying 
 
The deformation of the bladder y can be obtained by considering the static equilibrium for 
the bladder wall.  
 
 pi – KB y = 0                 
  
  
 (5-13) 
 
 With contact 
In this case, the gap between the shell and the limb is less than the total height of the 
bladder after supplying (h > d). Therefore, there is contact between the bladder and the 
limb and the radial deformation of the limb is not zero (x 0). Moreover, in this condition, 
there is contact pressure in the contact areas. In the figure 5.15, the contact condition is 
depicted. 
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Figure 5.15. The contact condition - The gap between shell 2 and the limb 3 is less than the height of 
the bladder 1 after air supplying 
 
By considering the equilibrium for the bladder wall and skin, the following equations can 
be expressed for this condition. 
 
   
  
  
 (5-14) 
   
  
  
         (5-15) 
 
With pC expressed as per equation (5-6). 
The two conditions for the contact characterization are implemented in the MATLAB-
SIMULINK as it shows in figure 5.16. 
 
 
Figure 5.16. The contact characterization implemented in MATLAB-SIMULINK 
Mathematical model of the IPC device                                                                              62 
 
 
 
5.3 Simulation of the whole model 
The mathematical model with all subsystems which were characterized in the previous 
sections is implemented in the Simulink as figure 5.17.  
 
 
Figure 5.17. The implemented model of the IPC device in MATLAB-SIMULINK 
 
The inputs of the model are the command signal and the supply pressure ps and the 
outputs are the bladder pressure pi and the contact pressure pc. 
  
5.4 Validation of the mathematical model   
In order to verify the effectiveness of the mathematical model, it has been numerically 
simulated for the bladder number 3 of the IPC prototype. The physical and operating 
conditions for the system are shown in table 5-1. 
 
Table 5-1. Experimental and simulated conditions 
Parameter Symbol Value  Unit 
Absolute supply pressure PS 1.5·10
5 
 Pa 
Absolute ambient pressure PA 1·10
5
 Pa 
Contact area of the bladder A 0.015 m
2
 
Pneumatic conductance C 3·10
-10
 m
3
/(s·Pa) 
Critical pressure ratio b 0.02 (inflating)  
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0.2 (deflating) 
Temperature T 293  K 
Temperature coefficient KT 1  
Bladder height at rest h0 0.006  M 
Initial shell-limb gap d0 0.01 M 
Bladder stiffness KB 5·10
5
 Pa/m 
Muscle stiffness KM 7·10
6
 Pa/m 
Inflating time ti  4 S 
Total cycle time tC 13 S 
 
A validation of the numerical model has been made by comparing the simulation with the 
experimental registration of the dynamic bladder pressure during the operation of a 
prototype. 
The figure 5.18 shows the experimental registration of the relative internal bladder 
pressure in comparison with the one simulated by the numerical model in the same 
condition. The figure reports also the contact pressure calculated by the model.  
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Figure 5.18. Comparison between the real and simulated relative bladder pressures 
 
According to the figure 5.18, the following remarks may be done: 
 The inflating condition is well simulated: the model reaches the same value of the 
bladder pressure with quite a similar dynamic behaviour. 
 The simulation of the deflating phase shows some difference from reality: this could 
mainly due to the identification of the bladder stiffness, which is considered constant in 
the model but should be more likely defined as increasing with the pressure. 
In general, the model is able to simulate the main dynamic behaviour of the bladder thus 
providing a tool useful to foresee the dynamic evolution of the internal pressure and the 
contact pressure on the limb, as a function of the main physical characteristics of the 
device and the control conditions. 
 
5.5 More simulations of the mathematical model 
The model has been used to simulate the sensitivity of the device to the variation of 
several parameters. All simulations have been made by varying one parameter at a time 
starting from the “nominal condition” reported in table 5-1.  
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The figure 5.19 reports the maximum values of the relative bladder pressure and the 
contact pressure, as a function of the initial shell-limb gap d0, the bladder height at rest h0, 
the bladder inflating time t1 and the relative air supply pressure pS . 
 
 
Figure 5.19. Maximum values of bladder pressure and contact pressure as a function of: initial shell-
limb gap d0 (a); bladder height at rest h0 (b); inflating time t1 (c); relative air supply pressure pS (d) 
 
Moreover, the model has been used to simulate the dynamic evolution of bladder pressure 
and contact pressure supposing a very fast command cycle, with 1 s inflating time and 1 s 
deflating time. The result is reported in figure 5.20 and shows behaviour of the device 
similar to the tetanus phenomenon in skeletal muscles. 
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Figure 5.20. Bladder pressure and contact pressure for a fast command cycle 
 
According to the figures 5.19 and 5.20, it can be deduced that the model is sensitive to the 
variation of the parameters and highlights the way this latter influence the action on the 
human. Thus, it is possible to obtain important indications on the values that must be 
respected in the design phase of the device. 
For instance, figure 5.19(a) shows the influence of the initial gap on the device 
performance, this demonstrates the importance of considering the anatomical aspects in 
the development of the device. Also it shows that by increasing the initial gap, the exerted 
energy to the limb decreases and as a result the maximum bladder pressure and contact 
pressure are decreased too. 
The figure 5.19(b) gives indications on the shape and material of the bladder: a high value 
of the parameter h0, convenient for the performance, can be achieved both using a soft 
material and choosing a shape allowing high dilatation with no stretching of the wall. The 
enhancement of the h0 causes the deceasing in the distance between the bladder wall and 
the skin. Therefore, more energy can exert to the limb and the contact pressure increasing. 
From figures 5.19(c) and 5.20, it is possible to get indications on the relationship between 
the control command and the characteristics of the pneumatic circuit, including the 
bladder volume, the air supply pressure and all the pneumatic components. From such 
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simulations, it is possible to foresee the dynamic performance of the device and recognize 
the maximum operating velocity that can be reached by the device. For instance in figure 
5.19(c), it can be observed that the optimum inflating time is 6 s to reach the value of 
supply pressure in the bladder. Increasing this value after 6 s, does not have any influence 
on the exerted pressure and only it wastes the energy. 
Figure 5.19(d) shows how the device performance may be influenced by the value of the 
air supply pressure, for a given configuration of the physical parameters and the control 
law.  
 
5.6 Specification of the initial gap d0 and transversal muscle stiffness KM 
for the model 
Initial gap d0 and transversal muscle stiffness KM are two parameters that cannot be 
determined exactly. The value of d0 depends on the fastening of the IPC device and its 
adaptability to the leg anatomy of the person. On the other hand, the value of KM , as 
mentioned before, depends on the condition of the muscle and the region of the leg. As it 
can be observed in section (5.2.1), the experimental tests on three persons showed a range 
of the value for KM. Therefore, to have the exact results and to do the more actions on the 
system such as controlling of it, it is necessary to know the best value of the parameters, 
which are close to real condition.   
The following steps can describe a method to estimate the values of KM and d0 for using in 
the obtained model of the IPC device: 
1. Simulation of the model for different combinations of KM and d0 values, and 
generating a table reporting the maximum value of pi in terms of KM and d0; 
2. Obtain the experimental value of pi by applying the device to the person for a 
given number of cycles; 
3. Find the experimental maximum value of pi in the table of step 1, and individuate 
a corresponding combination of KM and d0 for the model. 
The simulation results for the maximum inner pressure pi of the bladder in terms of the 
different values of KM and d0 are shown in the figure 5.21 and table 5.2. 
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Figure 5.21. The maximum value of the inner pressure pi of the bladder in terms of d0 and KM 
 
Table 5-2. The maximum value of the inner pressure of the bladder in terms of d0 and KM 
   KM       
    (
  
 
) 
do 
(m) 
3.0E+06 3.5E+06 4.0E+06 4.5E+06 5.0E+06 5.5E+06 6.0E+06 6.5E+06 7.0E+06 7.5E+06 8.0E+06 
0.005 46011 47133 47998 48658 49153 49511 49757 49909 49985 50000 50000 
0.006 45009 46124 47012 47720 48285 48734 49087 49364 49575 49732 49849 
0.007 43939 45029 45914 46641 47241 47738 48152 48498 48787 49028 49229 
0.008 42982 44024 44879 45591 46189 46693 47125 47494 47812 48087 48326 
0.009 41985 42971 43787 44471 45050 45546 45974 46346 46672 46958 47212 
0.01 41008 41933 42701 43347 43898 44372 44785 45146 45464 45747 45999 
 
In addition, the experimental result for the bladder in two cycles is depicted in figure 5.22. 
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Figure 5.22. The experimental record of the inner pressure of the bladder pi 
 
As it can be observed from figure 5.22, the maximum value of experimental Pi is 45320 
Pa. According to the table 5.2, this exact value is not in the table but there are some 
values close to it, included in the green zone of table 5.2. How to choose the best values 
depends on the conditions of the bladder. The region of the leg, where the bladder is 
acting, is an important parameter. For instance, for the bladders 4 to 6 the value of the 
muscle stiffness KM is smaller than that of bladders 2 and 3. Because in the upper region 
of the leg, there is muscular tissue, while in the lower part there are ligaments and bone. 
Also for the d0, the adaptability of the device for the bladders 4 to 6 is better than the 
bladders 2 and 3 and the value of the gap between bladder and skin in this region is less. 
The other parameter can be affected to select value from the table, is the type of the 
person. Obviously, the muscle stiffness is different between the normal person, patients 
and an athlete or between young people and old people. Totally, according to the 
mentioned parameters, therapist can select the value of KM and d0 for the simulation, 
based on the experimental record of pi.   
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In the case analysed here, the bladder is number 3 and the best selection could be KM= 
7*10
6
 Pa/m and d0 = 0.01 m. This simulation was shown in the figure 5.18 and the figures 
validate the proposed method. 
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6. CONTROL OF THE IPC DEVICE 
 
In this chapter, based on the mathematical model, two control strategies are developed for 
the IPC device. The aim is to create a desire pressure pattern on the limb surface. This 
latter have been done by using PID controller with proportional components for regulating 
the pneumatic quantities of the system, and also regulating the inflating time of the 
bladders. 
In addition, the experimental test for controlling the device base on the PID controller is 
presented. 
 
6.1 Control of the IPC device by regulating inflating time 
The value of inflating time ti is an important parameter in the IPC device and has a 
significant role in the operation of the device. Selecting the wrong value for inflating time 
may causes applying the different pressure from the required pressure on the limb. The 
inner pressure of the bladder does not reach to the desired value when the inflating time is 
less than the required one. In this case, the device does not have the positive influence on 
the cardio circulatory system. On the contrary, if the value of inflating time is more than 
the required one, the pressure on the limb increases and its tissues and vein may be 
damaged. Therefore, the control of inflating time can increase the performances of the 
device to have the best results. 
To understand the influence of the inflating time on the inner pressure of bladders, the 
inner pressure of a bladder for 3 and 4 seconds inflating times are experimentally 
registered and shown in the figure 6.1. 
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Figure 6.1. Inner pressure of a bladder for two different inflating times (4 s and 3s) 
 
As it can be observed in the figure 6.1, in the same condition, one second different in the 
inflating time causes about 5000 Pa difference in the inner pressure of the bladder. 
Therefore, controlling the inflating time in such IPC device is required. 
In the following, two methods (offline and online methods) based on the mathematical 
model are proposed to control the value of the contact pressure pc by regulating the 
inflating time ti.  
 
6.1.1 Offline method 
In this method, the control of the contact pressure between bladder and skin can be 
implemented by determining the time constant of the bladder. In this case, time constant τ 
is the constant represents the time that takes the contact pressure to reach 1-1/e   63.2% 
of the value of supply pressure. Equation (4.1) shows the definition of the time constant.  
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Pactual = Ps (1 - e
- 
 t
  ) 
 
(6-1) 
 
The procedure of the method is that, at the first, the model is simulated for two or three 
cycles. Then, the time constant of the bladder can be determined and apply to the model to 
simulate the next cycle operations. In figure 6.2 the first two simulated cycles for the 
bladder is depicted. 
 
 
Figure 6.2. The inner and contact pressure of a bladder in two cycles 
 
In the simulation the supply pressure ps considered as 5*10
4
 (Pa) relative to the ambient 
pressure, So the time constant of the bladder can be calculated as τ = 2.437( s). If the 
desired contact pressure pd is considered as 3.5*10
4
 (Pa), the required time to inflate the 
bladder can be obtained by substituting the value of the Ps and Pd in equation 6-1. The 
desired time td can be obtained as:  td   1.2 τ = 2.92 s. 
0 5 10 15 20 25 30
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
x 10
4 inner pressure and contact pressure
Time (s)
P
re
s
s
u
re
 (
P
a
)
 
 
bladder pressure
contact pressure
difference
Control of the IPC device                                                                                                   74 
 
 
By using the obtained desired inflating time, the system can be simulated for several 
cycles. In figure 6.3 the simulated cycles by using the desired inflating time is shown. 
 
 
Figure 6.3. The simulated cycles for the bladder by using the desired inflating time 
 
According to the figure 6.3, the bladder inflates until the desired inflating time td, and then 
PLC commands the valve to change the state, to the steady state to keep the inner pressure 
constant. Therefore, the contact pressure remains constant until 4s; and after that the 
discharging will be started. 
Keeping the contact pressure in the desired value, helps to apply the desired force on the 
muscle for more times and it has positive effect to recover the cardiovascular efficiency. 
To increase the time of the applying desired pressure to muscle, it is possible to increase 
the whole time of the keeping pressure or increasing the supply pressure. 
 
6.1.2 Online method 
In this method, the contact pressure pc is measured automatically through the simulation 
and in the same time, it is compared with the desired one. If the contact pressure is less 
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than desired one, the bladder continues to be charged, else the charging valve will be 
closed and the value of the contact pressure remains constant until the end of the inflating 
time. After the whole time of the inflating, the discharging valve will be opened and the 
deflating will be started. This control procedure can be done by PLC to update the 
command signal every moment. In this method opposite of the Offline method, the 
simulation of the model to determine the time constant before operating the device is not 
required. The scheme of the online method is depicted in the figure 6.4. 
 
 
Figure 6.4. The Scheme of the online method 
 
In the figure 6.5, the simulated contact and inner pressure of the bladder in the on line 
method is depicted. 
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Figure 6.5. The simulated contact and inner pressure of the bladder in the online method 
 
As it can be observed in the figures 6.3 and 6.5, control of the contact pressure and 
inserting its desired value for more time are achieved. Regarding to the results of both 
control methods (Offline and Online), it can be deduced that for each cycle of the 
simulation the bladder can apply on the limb the desired contact pressure about 1.5( s), 
which is about 37% of the inflating time. Since the rising time in each cycle is constant, 
by increasing the inflating time, the rate of having the contact pressure on the limb will be 
increased. For instance, if the inflating time is considered as 7s, about 65% of the inflating 
time, system works on the desired value. While without controlling the contact pressure 
(Figure 6.2), the system only passes the desired value and goes over until the end of the 
inflating time. Having the pressure more than the proper value may damage the device by 
exploding the bladder or the limb tissue like vessel rupture. 
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6.2 PID control of the IPC device 
6.2.1 General description of PID controller 
Proportional-Integral-Derivative (PID) is well-established and popular technique for many 
real-world control problems. This is due to its simplicity from both the design and the 
parameter-tuning point of view [71].  Since the invention of PID control in 1910 (Elmer 
Sperry’s ship autopilot) [72], and Ziegler-Nichols’s tuning methods in 1942[73], the 
popularity of PID control has grown all over the world. In this method, the proportional, 
integral and derivative terms are summed to calculate the output of the controller. 
Defining e(t) and u(t) as the input (error) and output of the controller respectively, the PID 
algorithm is: 
 
                       
 
 
    
 
  
     (6-1) 
 
And its transfer function is: 
 
          
 
 
          
 
   
      (6-2) 
 
Where KP, KI and KD are proportional, integral and derivative gains respectively; TI is the 
integral time constant and TD is the derivative time constant. The action of the three terms 
can be described as [74]: 
1. The proportional term: providing an overall control action to the error signal through 
the all-pass gain factor. 
2. The integral term: reducing steady-state errors through low-frequency compensation 
by an integrator. 
3. The derivative term: improving transient response through high-frequency 
compensation by a differentiator. 
In addition, the individual effect of increasing each term on the closed-loop performance 
is shown in Table 6-1. 
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Table 6-1. Effect of the gain increasing on the closed-loop response 
Closed-loop 
response 
Rise time Overshoot 
Settling 
time 
Steady-state 
error 
Stability 
KP Decrease Increase 
Small 
increase 
Decrease Degrade 
KI 
Small 
decrease 
Increase Increase Large decrease Degrade 
KD 
Small 
decrease 
Decrease Decrease Minor change Improve 
 
Several methods can be used to tune the PID control loop, based on the dynamic model 
parameters. Manual tuning, Ziegler-Nichols [73-78], Cohen-Coon [77,78] and software 
tools are the usual methods to tune the PID controller. Depending on the value of the 
terms, PID controller can be called PI and PD controller in the absence of the derivative 
and integral terms respectively. 
 
 6.2.1.1 Ziegler-Nichols (Z-N) method 
This pioneer method, also known as the close-loop or on-line tuning method was proposed 
by Ziegler and Nichols in 1942. Like all the other tuning methods, it consists of two steps: 
1. Determination of the dynamic characteristics, or personality, of the control loop 
2. Estimation of the controller tuning parameters that produce a desired response for 
the dynamic characteristic determined in the first step, in other words, matching 
the personality of the controller to that of the other elements in the loop. 
In this method the dynamic characteristic of the process are represented by the ultimate 
gain of a proportional controller and the ultimate period of oscillation of the loop. It 
usually determinate the ultimate gain and period from the actual process by the following 
procedure: 
 Switch off the integral and derivative terms of the feedback controller so as to 
have a proportional controller. 
 With the controller in automatic (i.e., the loop closed), increase the proportional 
gain until the loop oscillates with constant amplitude. Record the value of the gain 
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that produces sustained oscillation. To prevent the loop from going unstable, 
smaller increments in gain are made as the ultimate gain is approached. 
 
To tune a controller using the Z-N method the integral and derivative elements of the PID 
controller are ignored. The proportional element is used to find a Ku that will sustain 
oscillation. This value is considered as the ultimate gain. The period of oscillation is the 
Pu, or ultimate period. Consequently, Z-N settings are reasonable to apply in controller 
tuning using table 2.1. 
 
Table 6-2. Controller Settings Based On the Z-N Method 
Control type KP KI KD 
P 0.5 Ku 0 0 
PI 0.45 Ku 1.2 KP/Pu 0 
PD 0.8 Ku 0 KP Pu/8 
PID 0.6 Ku 2 KP/Pu KP Pu/8 
 
 
6.2.2 Application of PID controller to the model 
The scheme of the system in presence of the PID controller can be described as shown in 
figure 6.6. 
In the IPC device, the contact pressure pc is considered as output controlled value, while 
for the regulated value, there are two distinct possibilities. Supply pressure pS and mass 
flow rate Q are two different quantities that can be regulated by PID controller to track the 
reference pC. In the following, both methods to control pC based on regulating pS and Q 
are described. 
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Figure 6.6. The scheme of the system with PID controller 
 
6.2.3 System control based on regulating pS 
In the simulation and experimental validation shown in figure 5.18, the supply pressure to 
the system was kept constant and equal to 5·10
4 
Pa relative. The value of the internal 
bladder pressure and the contact pressure was then determined by the natural dynamic 
characteristic of the pneumatic circuit and by the inflating/deflating times commanded by 
the PLC. If a feedback was available (e.g. the contact pressure or the inner bladder 
pressure), the supply pressure to the system could be regulated by a PID closed loop 
controller for optimal tracking of the desired value. This can be done by proper integration 
of an electro-pneumatic pressure proportional valve (PPV) into the system. Such 
component will transform the electrical input signal sent by the controller into the supply 
pressure to the IPC device. 
Figure 6.7 shows the block scheme of the single-bladder system with supply pressure 
controlled by pressure proportional valve (PPV). 
 
 
Figure 6.7. Block scheme of the system with supply pressure (Ps) controlled by pressure proportional 
valve (PPV); contact pressure (Pc) is the outlet from bladder (B) 
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Figure 6.7 shows the block scheme of the single-bladder system with supply pressure 
controlled by pressure proportional valve (PPV). 
To design the PID control, the mathematical model of the PPV has been integrated in the 
model. The parameters of the device were maintained as reported in table 5-1. The model 
of the PPV can be represented by the block diagram shown in figure 6.8 [79], where Kv is 
the flow coefficient, Tv is the time constant and Cv is the interior capacity of the 
proportional valve. Pin and Pout are the input and the output pressure of the proportional 
valve respectively. For a commercial proportional valve type Festo MPPE-3-1/4, which 
has been considered in simulations, the parameter values are Kv=5·10
-7
 (m
3
/Pa.s) , 
Tv=0.01 (s) and Cv=1.43*10
-8
 (m
3
/Pa). 
 
 
Figure 6.8. Block diagram of a pressure proportional valve 
 
To tune the PID controller, the mix method of Ziegler-Nichols and manual tuning has 
been used. Since the whole system is represented by a highly non-linear and stiff 
mathematical model, the first step, consisting on the determination of PID coefficients 
(KP, KI, KD) by means of Ziegler-Nichols methods, was not sufficient to produce 
satisfactory results. Thus the first attempt values were changed by further manual fine-
tuning, according to the criteria of Table 6-1, for an optimal result. 
With a reference contact pressure of 3.5*10
4
 (Pa) relative to the ambient in inflating and 
zero in the deflating state, the best tuning was found with the coefficients: KP= 0.03 , KI = 
0, KD = 0.0044 , i.e. in this case the best solution corresponds to a PD controller.  
In figure 6.9, the reference and the actual contact pressure of the controlled system are 
shown. The graph reports also the error, i.e. the difference between reference and actual 
pressure.  
 
Control of the IPC device                                                                                                   82 
 
 
 
Figure 6.9. The reference and actual contact pressure of the bladder with PD control of the supply 
pressure 
 
The results of figure 6.9 show the effectiveness of the control: the actual pressure reaches 
the desired value in less than 2 seconds and it is maintained until the end of the inflating 
phase. 
To obtain this result, the controller must command in a proper way the proportional valve: 
this is testified by figure 6.10, which shows the variation of the absolute supply pressure 
PS, operated by the pressure proportional valve. At the beginning of the inflating phase, 
the supply pressure reaches the saturation level (2 bar absolute), so speeding as much as 
possible the rising of the bladder and contact pressures. 
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Figure 6.10. The variation of the supply pressure controlled by the proportional valve 
 
The saturation level of the supply pressure, which can be set by the controller, determines 
the response speed of the system, in particular the rising time of the bladder pressure. 
Defining the rising time as the time required for actual bladder pressure to rise from 10% 
to 90% of the reference value, figure 6.11 shows the variation of the rising time versus the 
saturation level of the supply pressure, as calculated by the mathematical model. 
Therefore the curve of figure 6.11 can be used to choose the most convenient value for the 
saturation level of the pressure proportional valve. 
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Figure 6.11. Variation of the rising time versus the saturation level of Ps 
 
A further sensitivity analysis was performed to investigate the influence on system 
performance of the transversal muscle stiffness KM, which was recognized as a very 
critical parameter to be identified. Like in the previous case, the rising time of bladder 
pressure in inflating phase was considered to represent the IPC dynamic performance. 
Figure 6.12 represents the variation of the rising time in terms of variation of KM. 
 
2 3 4 5 6 7 8 9 10
0
0.5
1
1.5
Max level of saturation Ps absolute (bar)
R
is
e
 t
im
e
 (
s
)
Control of the IPC device                                                                                                   85 
 
 
 
Figure 6.12. Rising time versus transversal muscle stiffness KM 
 
Figure 6.12 shows the result of the analysis: for KM varying from 7 to 3 MPa/m, the 
rising time increases of about 38%. This is certainly a noteworthy indication, which 
suggests the search for more effective control solutions in the continuation of research. 
  
6.2.4 Control of the system based on regulating Q 
The air pressure inside the bladder can be controlled directly by regulating the air flow 
rate. In this case, the supply to the bladder must be controlled by an electro-pneumatic 
flow-proportional valve (FPV), commanded by the PID control. In fact, referring to 
equation (5-3), the mass flow rate Q entering the bladder is directly related to the 
derivative of the pressure; therefore, to control the pressure it will be necessary to act on 
the valve conductance C, as defined in equation (5-1). 
Figure 6.13 shows the scheme of such a system. In particular, FPV is a 3-way flow 
proportional valve, whose conductance C can be regulated in analogical way by the 
controller. 
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Figure 6.13. Scheme of the single-bladder system with PID controller and flow proportional valve 
(FPV) 
 
Figure 6.14 shows a block scheme of an electro-pneumatic flow-proportional valve [80], 
where K is the electro-pneumatic gain and Tv is the time constant of the valve. Referring 
to a commercial proportional valve type Martonair SPGB 18913, the characteristic values 
are: K=1*10
-9
  m
3
/Pa/s/A and Tv=0.1 s. 
Applying to the system the mixed Ziegler-Nichols plus manual tuning method previously 
described, the PID coefficient has been calculated. The optimal result has been obtained 
with KP=0.005, KI=0 and KD=0.001.Also in this case the best configuration corresponds 
to a Proportional-Derivative PD controller. 
 
 
Figure 6.14. Block diagram of a flow proportional valve 
 
The mathematical model including the optimized PID controller and the flow-proportional 
valve has then been simulated. Figure 6.15 reports the result of the simulation, showing a 
comparison between the actual and reference contact pressure, as well as their difference 
(error). The result is very similar to the one produced by the control with regulation of the 
supply pressure: this confirms that also the solution with flow regulation is theoretically 
able to control the device in an effective manner. 
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Figure 6.15. The reference and actual contact pressure of the bladder with PID control and the flow 
rate regulated by a proportional valve 
 
Figure 6.16 shows the variation of the valve conductance, under the regulation of the PID 
controller. A positive value corresponds to inflating condition, and vice-versa. 
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Figure 6.16. The variation of the valve conductance 
 
6.2.5 Parallel control of 3 bladders by one pressure proportional valve 
In section 6.2.3 the way to control a single bladder with one pressure proportional valve 
and a PID controller was described. Actually, an IPC device includes a given number of 
bladders, which must be controlled in a coordinated way, in order to generate a definite 
pressure pattern on the limb surface. It is supposed that the device should generate a 
peristaltic and centripetal pressure wave, i.e. proceeding from distal to proximal position, 
in order to facilitate the venous blood return to the heart. To this aim, the activation 
sequence of the bladders must follow the same logic. Thus a definite reference pressure 
must be tracked in any bladder. In addition, for cost and complexity reasons, it would not 
be permissible to have a proportional valve for each bladder. Therefore, a system of three 
bladders controlled by one PID controller and one pressure proportional valve has been 
studied and simulated.  
For such a multi-bladder system the controller, acting as a PLC, must switch among the 
bladders, commanding the proper on-off control valve, selecting the proper contact 
pressure feedback and sending the proper pressure reference to the PID controller. A 
possible scheme of the system is presented in figure 6.17, where , posing n=1,2,3, Bn are 
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the bladders, Vn are the corresponding on-off control valves, Pn are the bladder-limb 
actual contact pressures, PPV is the pressure-proportional electro-valve. 
 
 
Figure 6.17. 3-bladder system with one pressure-proportional valve (PPV) controlled by PID 
 
In the model the three bladders have been configured with different parameters, including 
the contact area A, the transversal muscle stiffness KM of the leg region where the bladder 
acts on, and the gap between the bladder and leg d0. The values of such parameters, which 
are shown in table 6-3, were selected in such a way as to represent possible variations due 
to muscular condition, location of the bladder on the limb and different device dressing 
that may occur using the actual prototype. In particular, with parameter values of table 6-
3, the system is configured in such a way as to present increasing response time from 
bladder 1 to bladder 3. 
 
Table 6-3. Parameters of the 3 bladders 
 Contact area A 
(m
2
) 
Muscle stiffness KM 
(Pa/m) 
Gap d0 
(m) 
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Bladder 1 0.014 7.10
6
 0.006 
Bladder 2 0.017 6.10
6
 0.009 
Bladder 3 0.02 5.10
6
 0.012 
 
The inflating and deflating times, imposed by the PLC for each bladder, are 4s and 9s 
respectively, and the three cycles were shifted to produce a peristaltic effect, as it is shown 
in the command sequence of figure 6.18. When command is OFF the reference pressure is 
0, when command is ON the reference pressure is set at a defined value for all bladders. 
 
 
Figure 6.18. Command sequence of the three bladders 
 
The system has been simulated in two conditions: 
a) Without proportional valve and PID control: each control valve Vn is supplied at 
0.5*10
4
 Pa relative pressure 
b) With proportional valve and PID control: the absolute supply pressure to the 
valves Vn is regulated by the proportional valve and is saturated at 2*10
5
 Pa; the 
relative reference pressure to the PID is set to 3.5*10
4
 Pa  in inflating state and 0 
in deflating state, for all bladders. 
Figure 6.19 shows the simulation results without PID controller (a) and with PID 
controller (b). 
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Figure 6.19. Simulation of the multi-bladder system in absence (a) and in presence (b) of the PID 
controller 
 
The simulation shows that an effective control of the bladder actions is almost impossible 
without a feedback control system, since the dynamic behaviour and the maximum level 
of the pressures are affected by a number of randomness that are difficult to evaluate 
properly. As it can be observed in figure 6.19(a), the dynamic behaviour and the 
maximum level of the contact pressure are very different among the bladders, that it is due 
to the differences imposed to the bladder parameters. On the contrary, when the PID 
controller acts on the system (figure 6.19 (b)), the contact pressure tracks much better the 
reference one, which is set at 3.5*10
4
 Pa, in each bladder. Obviously the feedback 
controller gives better result, and simply including feedback in the control of on/off valves 
would guarantee achieving of the desired pressure, but the use of a pressure proportional 
valve provides advantage also for the system dynamics and general tracking: in this case 
the bladders can be supplied with pressure much higher than the desired internal value, 
thus reducing the rising time and allowing to maintain the desired value for a defined 
period, as highlighted by figures 6.10 and 6.11. 
Due to the difference in the bladder parameters, the dynamic behaviours of the three 
bladders are still different, as highlighted by the rise and fall times, but each bladder can 
reach the reference contact pressure and maintains it for a significant time: totally, in a 
cycle of 13 s, the bladders 1, 2 and 3 can stay about 8s in the reference contact pressure, 
that is equal to 62% of the whole time. You should also consider that the tuning of the 
PID coefficients has been made for only one bladder, but gives acceptable results for the 
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whole system, thus testifying the ability to compensate in some extent also uncertainties 
like the actual value of the transversal muscle stiffness and the limb/device gap. 
 
6.3 Experimental tests of the PID control of the device 
In the section 6.2 the PID control for the mathematical model was described and the 
results showed the effectiveness of the control strategy on the device. Those simulations 
were implemented for both single and multi-bladder systems. In this section the 
experimental test based on the obtained data of the section 6.2 is explained. In the 
following the experimental results for both the single bladder and multi-bladder systems 
are expressed.  
 
6.3.1 Experimental test to control of the single bladder system 
To control the system based on PID controller, the engineering software LabView and the 
related board National Instrument (NI) are used. The PID control is implemented on the 
system by means of a NI PCI 6036E board and the Festo proportional valve which is cited 
in section 6.2.3. A single bladder was placed in a test bench reproducing all conditions of 
table 5-1, including soft tissue stiffness KM (transversal muscle stiffness).  
The scheme of the experimental control test for the single bladder system is depicted in 
figure 6.20. 
 
 
Figure 6.20. The scheme of the experimental control of the single bladder system 
 
In this case, the pressure transducer PT measures the inner pressure of the bladder Pi Act 
and the obtained data is transferred to the LabView by the NI board. The PID control 
model determines the output signal for the acting on the pressure proportional valve PPV 
by regarding to the error of the system. The error of the system is the difference between 
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the reference inner pressure Pi Ref and the actual inner pressure Pi Act. Moreover the acting 
signal on the PPV also can be calculated by using the equation 6-1. 
The output signal of the PID controller acts on the PPV by NI board after some 
amplification. Base on the input signal, the PPV regulates the output pressure of the air to 
enter to the bladder. The mentioned close loop is iterated many times until the inner 
pressure of the bladder reach to the reference one. And then the control system maintains 
the desired pressure in the bladder. 
The result of the experimental control of the system is shown in figure 6.21. This figure 
reports the reference and the experimental inner pressure of the bladder. In this test the 
reference inner pressure is considered as 0.36 bar in inflating and 0 in deflating times. 
 
 
Figure 6.21. The experimental and reference inner pressure of the bladder in presence of the PD 
controller 
 
To compare the experimental results with the simulation ones (Section 6.2.3), the 
experimental Pi with the simulated reference and contact pressure of the bladder are 
represented in figure 6.22. 
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Figure 6.22. Reference and simulated contact pressure with PD control of the bladder supply, 
compared with the experimental inner bladder pressure 
 
As it can be observed in figure 6.22, there is a good correspondence between the 
experimental result and simulated one in dynamic behavior of the bladder in the inflating 
phase. Also it is interesting to note that the controller regulates the inner bladder pressure 
at a slightly greater than the reference contact pressure, taking into account the bladder 
stiffness. 
About the deflating phase, there is differences in the dynamic behavior of the bladder but 
in both (experimental and simulation) results the contact and the inner pressure of the 
bladder reach to the zero before the end of the deflating times and this case is more 
important to avoid from tetanus phenomenon. 
Consequently, it can be deduced from the comparison that the simulation results is 
verified by the experimental one and the figure shows the effectiveness of the proposed 
control strategy by using PID controller and proportional valve.  
According to the figure 6.21, the experimental inner pressure of the bladder reaches to the 
desired one less than 2 seconds and it is developed the efficiency of the device more than 
50%. This is an excellent result, taking into consideration the natural low dynamics of 
such pneumatic systems. 
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6.3.2 Experimental test to control of the multi-bladder system 
The experimental bench to control the multi-bladder system is developed by the same 
conditions mentioned in section 6.2.5. For the test, a pressure proportional valve (PPV) 
and a PID controller are used for whole 3 bladders and the PLC switch among the 
bladders the command signal which showed in figure 6.18. The scheme of the 
experimental control test for the multi-bladder system is depicted in figure 6.23. 
 
 
Figure 6.23. The scheme of the experimental control test for the multi-bladder system 
 
The experimental test in this case was done in the same condition with the simulation one 
(Sec. 6.2.5) and the results are depicted in the figure 6.24. In this test, the inflating and 
deflating times are considered as 4s and 9s respectively for each bladder and the reference 
value is 0.35*10
5
 bar. 
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Figure 6.24. The experimental inner pressure Pi for the three bladders in presence of the PD 
controller 
 
As it can be observed in figure 6.24, the control bench which describe in the previous part, 
works very good and it can control the inner pressure of the bladders to reach and stay in 
the reference value. By comparing the experimental results and simulated results (figure 
6.19 (b)) for multi-bladder system, it can be deduced that the experimental test verifies the 
simulation one in both dynamic behaviour of the pressure and the time of remaining in the 
reference value. 
 
6.3.3 Experimental test for the 3 bladders to simulate the fast mode  
This experiment is focused in a closer approximation to the muscle motion and pumping 
effect in the blood in a healthy human. The objective of this experiment is to achieve a 
similar performance in our prototype for handicapped people who do not have the lower 
limbs affected by a disease. 
The changes into the period of the cycles try to achieve the similitude with the human 
walk; tries to get closer to the peristaltic wave the muscles provide in healthy people. 
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The inflating and deflating times in this experiment are considered as 2s and 5s 
respectively. So, the PID controller has much less time to adapt the signals up to 35000 
Pa. The experimental result for the simulation of fast mode is shown in figure 6.25. 
 
Figure 6.25. The experimental inner pressure Pi for the three bladders in presence of the PD 
controller for Fast mode 
 
 According to the figure 6.25, in the fast mode, the dynamic behaviour of the bladders are 
almost similar to the normal mode (4s deflating time) and PD controller tries to reach the 
inner pressure to the reference one as soon as possible. The result shows that the controller 
works well in the fast mode and the system is stable in this condition.  
0 5 10 15 20 25 30
0
0.5
1
1.5
2
2.5
3
3.5
4
x 10
4
Time (s)
P
re
s
s
u
re
 (
P
a
)
 
 
Bladder 1
Bladder 2
Bladder 3
Conclusion                                                                                                                        99 
 
 
 
 
 
 
7. CONCLUSION 
 
Goal of the project is the realisation and control of a biomechanical robotized Intermittent 
Pneumatic Compression (IPC) device to accomplish a therapeutic methodology for the 
recovery of cardio circulatory function in paraplegic patients. This impairment causes by 
the reduction of Venus return to the heart due to the absence of leg muscle contraction. 
The most advanced of the IPC device can produce defined compression/relaxation 
patterns on limb surfaces, improving the peripheral venous flow even in immobilized 
patients.    
Despite there are many researchers investigating on IPC effects, the lack of a general 
methodology to study and develop an IPC device with physical and dynamical 
characteristics suitable for the intended application, is evident. In particular, the dynamic 
behaviour of the device in response of the control command is practically ignored. 
The research activities and the accomplishments of this thesis can be categorized in the 
following three sections: 
1. Designing and realization of the IPC device. Two prototypes of the IPC device 
were made in the laboratory of the Polytechnic University of Turin, which have 
been included 6 inflated bladders, shell to support the bladders and control system. 
The control system consists the 6 micro-electro valves, a programmable logic 
controller (PLC) and the pressure sensors for dynamic monitoring of air pressure 
inside bladders. The first one was with rigid body shell to support the bladder and 
it causes some problems to fit and adaptability of the device to the shape and 
dimension of the limb. Therefore, to eliminate the problems, in the second 
prototype, instead of the rigid body, the flexible and inextensible tissue is used to 
support the bladders. The prototype was tested experimentally on the 19 voluntary 
subjects and by the Echocardiography device the important parameters of the 
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cardiovascular system were recorded. The results of the experimental tests showed 
that the IPC device can improve the stroke volume (SV) +16% , the cardiac output 
(CO) +9.4%, and the end diastolic volume of left ventricle (LVEDV) +10%. 
2. Mechanical characteristic and mathematical model of the IPC device. After 
validating the effectiveness of the IPC device on the cardiovascular system, we 
decided to model the device mathematically, to understand the dynamic behaviour 
of the IPC device and its interaction with the human, what it has been not 
considered in the literature. The obtained mathematical model considered all 
physiological and mechanical principles. To characterize the pneumatic circuit and 
device-limb interaction, we calculated all the parameters like transversal muscle 
stiffness and bladder stiffness experimentally. The transversal muscle stiffness is 
the most critical parameter, because its value depends on the muscle conditions. 
For example, there is different muscle stiffness between patients, normal persons 
and athletes. In this study, we have proposed the new method to estimate 
experimentally the value of the transversal muscle stiffness.   
The mathematical model has been implemented in Matlab-Simulink®, and 
simulations have been compared to experimental tests carried out on the prototype 
of IPC device, for validation. The results have shown that in both dynamic 
behaviour and maximum level of internal bladder pressure, the simulation has 
been verified by experimental one. So, the mathematical model can be used as a 
tool to simulate the real dynamic behavior of the IPC device and predict the effect 
produced on the limb, mainly the contact pressure and to define its control logic.  
The model is sensitive to the variation of the parameters and highlights the way 
this latter influence the action on the human. Thus, it is possible to obtain 
important indications on the values that must be respected in the design phase of 
the device. 
3. Control of the IPC device. In this section, the main issue is to individuate a proper 
control strategy able to create a desired pressure pattern on the limb surface, 
corresponding to a peristaltic and centripetal pressure wave. So, two control 
strategies was implemented in this research. 
- Control of the bladder pressure by regulating the inflating time of the 
bladder. The value of inflating time is an important parameter in the IPC 
device. The experimental tests showed that differences 1 second in inflating 
time causes about 5000 Pa differences in the bladder pressure. So, the device 
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was controlled by regulating the inflating time by using two methods: Online 
and Offline, and the results showed about 37% improving in working the 
system on the desired value of the pressure bladder for inflating time equal to 4 
s. 
- Control of the bladder pressure by applying a PID control properly tuned and 
to use proportional components for regulation of the pneumatic quantities of 
the system, i.e. the supply pressure and the air flow to the bladders. The results 
produced by this controller showed that the bladder can exert to the limb the 
exact value of the reference pressure for about the 60% of the desired active 
time (4 s). This is an excellent result, taking into consideration the natural low 
dynamics of such pneumatic systems. On the contrary, in absence of PID 
control the bladder pressure evolves only reaching a peak value, whose value 
is determined by the various parameters of the pneumatic circuit and is 
practically impossible to foresee.  
In addition, to verify the results of the control on the mathematical model, the 
device was controlled experimentally. The experimental tests were done by 
using the proportional components and engineering software LabView. The 
records showed a good corresponding between simulation and experimental 
results in both the dynamic behaviour of the device and stability of the 
pressure value in the desired one.  
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FUTURE WORK 
 
Future work will concern more accurate modeling of the physiological system, including 
also damping characteristic of the soft tissues and a complete model of the cardio-
circulatory system. This will allow to estimate the effect of the IPC device on the dynamic 
performance of the CCS, which is the final goal of the research. On this base, it will be 
possible to define also more precise patterns for the pressing action, which will constitute 
the reference for the study of more performing control algorithms. 
 
 
 
In addition, the device with controller which has been studied in this study can be test 
clinically in both healthy and impaired people to verify the effectiveness of the IPC 
device. 
+ +
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APPENDIX  
In this part, the three published papers based on the thesis in full format are presented.   
 
I. C. Ferraresi, D. Maffiodo, H. Hajimirzaalian, “A model-based method for the design 
of Intermittent Pneumatic Compression Systems acting on humans”, published in the 
Journal of Engineering in Medicine, Vol. 228 (2), pp. 118-126, 2014. 
URL: http://pih.sagepub.com/content/228/2/118 
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parameters in a robotized IPC device interacting with human” , published in Journal of 
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Control strategies of an intermittent pneumatic compression device for 
cardio-circulatory rehabilitation 
 
Carlo Ferraresi, Hamidreza Hajimirzaalian, Daniela Maffiodo 
Department of Mechanical and Aerospace Engineering 
Politecnico di Torino, Italy 
 
Abstract 
In immobilized people, like paraplegic subjects, due to absence of leg muscle contraction, 
venous return to the heart is reduced and this may induce important diseases like a 
reduction of cardiac output. The application to legs of a mechanical stimulation operated 
by an Intermittent Pneumatic Compression (IPC) device, in replacing striate muscle pump 
on limb veins, may recover in these patients venous return to the heart, thus restoring 
correct cardio-circulatory performance. This paper deals with the study of the effective 
way to control such a device. First a mathematical model of the whole human-machine 
system is realized and validated; then several control logics, based on the PID control of 
electro-pneumatic proportional components, are investigated; finally, an effective solution 
is defined to control a multi-bladder IPC device with adequate performance to the 
objective. 
 
Keywords: cardio-circulatory rehabilitation, intermittent pneumatic compression, IPC 
mechatronic device, multi-bladder pneumatic device, PID control, Man-Machine Systems. 
 
1. Introduction 
Nowadays, the great majority of rehabilitation robotized devices is addressed to mobility 
[1, 2] however, a robotized rehabilitation can be adopted also to deal with diseases 
affecting other physiological compartments, like the cardio-circulatory system (CCS). 
Actually, during any physical activity, the intermittent contraction of the limb muscles 
exerts important pumping action on physiological systems such as the muscular, 
cardiovascular or lymphatic system.  
In immobilized people, e.g. paraplegic subjects, due to absence of leg muscle contraction, 
venous return to the heart is reduced and this may induce a reduction of cardiac output 
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(CO). As a matter of fact, according to the well-known Starling’s law, “the output of the 
heart is equal to and determined by the amount of blood flowing into the heart, and may 
be increased or diminished within very wide limits according to the inflow”. In other 
words, the cardiac output is directly influenced by the venous return, which is determined 
primarily by the mechanical properties of the systemic circulation.  
Therefore it is reasonable to suppose that the application to legs of a mechanical 
stimulation operated by actuators, in replacing striate muscle pump on limbs veins, may 
recover in these patients venous return to the heart, thus restoring sufficient performance 
of the cardiovascular system. 
Since 1930s, it was evaluated that intermittent pneumatic compression (IPC) has a 
positive effect on lower extremity blood flow of calf and foot [3, 4]. Starting from a first 
commercial device designed during the sixties, many IPC devices were developed to 
accommodate different medical applications: to prevent deep vein thrombosis [5, 6], for 
the treatment of critical limb ischemia [7-9], to compensate congestive heart failure [10] 
and it was recommended for lymphedema treatment [11] and sport recovery [12, 13]. 
Studies have shown that IPC application on legs changes central venous pressure, 
pulmonary artery pressure, and pulse pressure [14] and IPC application on foot increases 
popliteal artery blood flow [15]. Moreover various researches have suggested that this 
mechanical method effectively reduces the incidence of the diseases without any side 
effects, increasing volume flow and velocities in deep veins [8, 9, 16].  
Various researchers [17, 18, 19] compared different commercial IPC devices and 
observed positive results, although devices were different and worked with different 
pressure values, cycle times and other parameters, thus indicating a poor knowledge of the 
relationship between the characteristics and settings of the device and the effects on the 
human 
Although it is possible to find in the literature the need for a more quantitative study of 
these devices, for example trying to model the deformation of the limb [20], the need to 
understand the dynamic behavior of the device, relating the supply pressure with the real 
operation pressure on the limb as a function of the device characteristic and the dynamic 
control of the actual limb/device contact  pressure, seems to be barely considered. Few 
researchers tried somehow to consider the effect of pressure level and inflation/deflation 
time [21]. Others [16], while comparing the behavior of two different commercial devices, 
conclude that not only the different levels of the air supply pressure have to be considered, 
but also the different behavior depends on the different patterns of pressure, garnments, 
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materials and design of the device. They also state that “further investigation of 
biomechanical mechanisms of IPC is needed to guide the development of better 
engineering solutions …”. 
Therefore, despite many researchers investigated on IPC effects, the lack of a general 
methodology to study and develop an IPC device with physical and dynamical 
characteristics suitable for the intended application is evident. In particular, the dynamic 
behavior of the device in response of the control command is practically ignored. 
The subject of this paper is the study of an effective control strategy for the realization of 
an IPC device able to act at the level of the cardio-circulatory system, in order to recover 
normal performance in impaired people. An IPC device is mainly composed by pneumatic 
elements: compressed air source, valves, pipes and bladders. A first step towards 
quantitative understanding of its dynamic behavior is modeling and identification of this 
pneumatic part of the device, which has a preponderant influence on system dynamics. 
Also, the interaction between device and limb is an essential part to determine the actual 
contact pressure, and must be modeled. 
The article starts with the description of an existing IPC prototype previously realized 
[22], then a simplified mathematical model of the system, considering limb/device 
interaction, is presented; based on the model, the definition and optimal tuning of a PID 
controller, considering only one bladder but for different system configurations, is 
proposed; finally the control of a multi-bladder system is discussed. 
 
 
2. The IPC device 
The present study is focused on a prototype device previously realized in our laboratory. 
Figure 1 shows the prototype and its basic functional scheme. It includes inflatable 
bladders (a) supported by shells (b, c), a pneumatic circuit with on/off electro-pneumatic 
valves (d) and a programmable logic controller (e) which imposes a defined command 
sequence to the valves, according to a predetermined protocol. 
The operating of the device is simple: by inflating the bladders with the compressed air, 
the pressure can be applied to the limb surface. The programmable logic controller (PLC) 
controls the valves with a defined time sequence, so as to arrange the sequential acting to 
the bladders and to generate a peristaltic and centripetal pressure wave on the limb. The 
design and realization of the prototype required several factors to be considered, aimed at 
achieving better performance. The main design criteria are described below. 
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Bladders are key elements of the system: in order to optimize the performance, the 
pneumatic energy should be directed as much as possible towards the limb soft tissues, 
rather than used to deform the materials of the device structure. To this aim, bladders 
should be free to expand with limited or null stretching of their wall, and this can be 
achieved both by proper shaping of the cells and adopting a material which is compliant 
but, of course, airtight. The number and dimension of bladders must allow to generate a 
pressure wave on the limb and at the same time to guarantee high response speed: it was 
assumed that one bladder acting on the foot sole and five acting on the calf were a good 
compromise. To realize the bladders, a special airtight and compliant tissue was selected: 
the Medical Windtex® (Windtex Vagotex S.p.A., Italy). 
Also the shells are fundamental elements of the device: a key aspect is choice of rigid or 
flexible structure. After evaluating a first prototype with rigid shells, with the drawback of 
variable and large gap between device and limb, the shells were conceived as a sort of 
sleeves, flexible but inextensible, so self-adapting to the shape and size of the limb but 
also avoiding stretching and therefore directing all pneumatic energy to the limb. To 
realize the shells, a special inextensible and airtight trilaminate tissue (Aqualight 160D®, 
D&D SNC, Italy) was selected. 
Also the pneumatic circuit was designed in order to favor high response speed: the six 
on/off electro-valves were placed onboard of the prototype, to shorten as much as possible 
the tubes for bladder supply, the choice of valves Festo type MHP1-M1H-3/2-M3 
provided a good compromise between lightness and flow rate. The circuit is controlled by 
a Siemens Logo! PLC, which imposes a defined opening/closing sequence to the valves. 
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Figure 1. Prototype of IPC device and its basic functional scheme: inflatable bladders (a), shell (b, c), 
electro-pneumatic valves (d), programmable logic controller (e) 
The main shortcoming of this system is the lack of direct control of the action actually 
produced on the limb. The dynamic evolution of the pressure in the bladders is due not 
only to the time sequence imposed by the PLC, but also to the characteristic of the 
pneumatic circuit, to physiological parameters of the subject and to the way the device is 
coupled with the limb. 
The work described in this article was devoted to the search of a more effective control 
technique, based on a Proportional-Integral-Derivative (PID) feedback controller and the 
use of electro-pneumatic proportional components for regulation of the pneumatic power.  
 
3. Mathematical model of the IPC device 
To understand the physical behavior of the device while acting on the human, an overall 
mathematical model is required, which must consider all physiological and mechanical 
principles, including all properties of the pneumatic circuit. The conceptual block diagram 
of the model can be described as in figure 2. 
 
Figure 2. Conceptual block diagram of the model 
 
The model is considered for a single module with one bladder supplied by one electro-
pneumatic digital valve. In the model, the supply pressure and the command signal of a 
PLC apply to the pneumatic circuit which is provided with a three-way valve for each 
bladder. The output of each valve is the air mass flow rate Q that can inflate (positive Q) 
or deflate (negative Q) any single bladder. By inflating the bladder, the inner pressure Pi 
increases and exerts the contact pressure Pc on the limb. Therefore, the limb deforms in 
the radial direction as x. The interaction between bladder and limb is named as human-
machine system. To model the system, it is required to characterize both subsystems 
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(pneumatic circuit and human-machine) and determine all mechanical and physiological 
parameters. As concerns notation, an uppercase P indicates absolute pressure, a lowercase 
p indicates relative to ambient pressure. 
To express the air mass flow rate through the valve, from upstream section (pressure P1) 
to downstream (P2) the following formula, according to the ISO 6358 standard [23], can 
be adopted:  
 
               
   
   
 
 
               for subsonic flow 
               for sonic flow 
(1) 
Where: ρ is the air density, C is the valve conductance, KT is a corrective factor depending 
on the inlet air temperature; r=P2/P1 is the actual pressure ratio; b is the critical pressure 
ratio at which the flow switches from subsonic to sonic condition. The conductance C can 
be considered positive or negative, thus determining inflating or deflating effect on the 
bladder. 
To characterize the human-machine subsystem, the scheme in figure 3 can be considered. 
 
 
Figure 3. Scheme of the human-machine system 
 
Where the main mechanical characteristics are the transversal stiffness KM of the soft 
tissues and the bladder wall stiffness KB. Pi is the pressure inside of the bladder; PC is the 
contact pressure between bladder and limb. x and y represent respectively the deformation 
of limb and bladder under the effect of the pressure. The actual height of the bladder is 
indicated as h, whose initial value (no pressure in bladder) is h0; d represents the actual 
distance (gap) between the shell and the limb, with initial value d0; in case of skin-bladder 
contact, it will be h=d. The initial values h0 and d0 represent the “rest condition” of 
bladder and limb respectively, i.e. when a null pressure is acting on the system. 
The internal bladder pressure Pi , assuming isothermal condition, can be calculated by 
integrating the continuity equation: 
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(2) 
 
Where R is the air constant, T is the absolute temperature, A is the bladder-limb contact 
area           is the actual volume of the bladder. 
According to figure 3, the following equations express the bladder-limb interaction: 
  
          (3) 
       (4) 
  
  
  
         (5) 
 
Transversal stiffness KM of soft tissues and bladder stiffness KB are two important 
parameters that are required to characterize the system. In general, KM should be 
considered as depending on limb deformation x and KB as depending on bladder 
deformation y. 
To evaluate the bladder stiffness, it is possible to measure statically the variation of 
bladder height as a function of the internal pressure. Of course, this characteristic has to 
be considered only from the “rest condition” on, indicated by the h0 value. As an example, 
figure 4 shows the result of the linearized characteristic of a tested bladder. 
 
 
 
Figure 4. Example of stiffness characteristic of a bladder 
 
The actual value of KB depends on the wall material, shape and dimension of the bladder. 
By way of example, a rectangular bladder of 5 by 30 cm sides, made of Windtex®, 
presents an average            of about 5·10
5
 Pa/m, with a rest thickness of 6 mm. 
According to the characteristic of figure 4, the equation (3) can be split to consider the full 
range of the bladder expansion: 
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(6) 
 
The soft tissue stiffness KM is the most critical parameter to be measured experimentally. 
Its value depends on the muscle condition: for example, there is different muscle stiffness 
between patients, normal persons and athletes. Moreover, on the same subject this 
parameter can be different in different areas of the limb. In addition, there is no 
information in literature and very few researchers like Dai et al. [20] tried to 
experimentally measure this characteristic. A possible way is to deform the limb by means 
of a band wrapped around it and correlate the reduction of the circumferential contact line 
with the tension applied to the band: it will be simple to derive the ratio between the 
pressure exerted on the limb and the radial deformation, which expresses the muscle 
stiffness          . Adopting this methodology, the test was performed on three 
healthy subjects (two females and one male), placing the test band on the belly of 
gastrocnemius muscle, asking the subjects to keep the muscle as relaxed as possible. For 
each subject the test was repeated three times, applying a contact pressure up to 45 kPa. 
The results showed in general a slightly “hardening” trend, but with considerable data 
dispersion. Therefore we decided to assume constant mean values as representative of the 
stiffness. The three average measured values were respectively of 2.9 MPa/m, 5.2 MPa/m 
and 7.1 MPa/m. 
Such a static identification does not take into account other effects like the typical 
damping of soft tissues, which would have been much more difficult to estimate. Future 
work is planned for more accurate identification of soft tissue characteristic, however 
considerable damping effect of the pneumatic system (circuit plus bladder) is taken into 
account in the mathematical model equations. 
The mathematical model here described has been implemented in Matlab-Simulink®, and 
simulations have been compared to experimental tests carried out on a corresponding 
prototype of IPC device, for validation. The prototype was applied to the leg of a healthy 
male subject and the internal pressure of the bladder located on the gastrocnemius belly 
was acquired. 
The physical and operating conditions for the system are reported in table 1. 
Figure 5 shows the result of the comparison. It emerges a good correspondence as regards 
the maximum value of the internal pressure and also the time occurring to reach it; while 
there is a certain difference in the dynamic behavior of the discharging phase. In the 
complex, the model shows a sufficient ability to represent the prototype dynamics. 
The model is also able to calculate the contact pressure pC, which is traced in figure 5 as 
well. The difference between bladder and contact pressure can be evaluated by means of 
the bladder stiffness considered in the model equations. 
 
Table 1. Experimental and simulated conditions. 
Parameter Symbol Value  Unit 
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Relative supply pressure pS 5·10
4 
 Pa 
Absolute ambient pressure PA 1·10
5
 Pa 
Contact area of the bladder A 0.015 m
2
 
Pneumatic conductance C 3·10
-10
 m
3
/(s·Pa) 
Critical pressure ratio b 
0.02 (inflating) 
0.2 (deflating) 
 
Temperature T 293  K 
Temperature coefficient KT 1  
Bladder height at rest h0 0.006  M 
Initial shell-limb gap d0 0.01 M 
Bladder stiffness KB 5·10
5
 Pa/m 
Soft tissue stiffness KM 7·10
6
 Pa/m 
Inflating time t1 4 S 
Total cycle time tC 13 S 
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Figure 5. Comparison between experimental and simulated relative bladder pressures. Contact 
pressure between bladder and limb is also calculated and traced. 
 
 
4. PID control of the device 
As concerns control of the IPC device, it must be considered that the final goal is not a 
precise tracking of the bladder pressure or the contact pressure, but the control of effects 
produced by the device on the cardio-circulatory system (CCS) performance. Such 
performance can be described by certain heart functional parameters like Heart Rate (HR), 
Stroke Volume (SV), Cardiac Output (CO), Ejection Fraction (EF), which can be 
monitored in real time during the device operation, or evaluated off-line after a training 
period. 
Currently poor knowledge exists on a direct correlation between a pressing action on the 
leg and corresponding effect on the CCS, therefore it is impossible to define an “optimal” 
reference function as regards the pattern of the applied pressure. 
IPC devices currently used for several applications are usually developed and employed 
on the base of empirical methods. The application protocol is almost always defined by 
the value of supply pressure to the on/off valves and their activation/deactivation times, 
but no knowledge exists about the actual pressure exerted in real time on the limb by the 
bladders. The major weakness is that the dynamics of the pneumatic section is not taken 
into account. 
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At this stage of the research the goal was to realize a prototype allowing to perform 
sufficiently significant clinical tests, deferring to a later stage further improvement 
actions, which will include of course control algorithms for bladder pressure tracking. 
For these reasons the main requirement for device control was not absolute dynamic 
accuracy, but simplicity and low cost of implementation, while ensuring sufficient 
performance in response time and ability to maintain an actual value of the desired 
pressure for a given time. 
In this context, a PID controller has been considered adequate, due to its simplicity from 
both the design and the parameter-tuning point of view [24]. Also implementation in the 
device is little demanding as concerns pneumatic hardware and instrumentation. 
To tune the PID controller, the mix method of Ziegler-Nichols [25] and manual tuning has 
been used. Since the whole system is represented by a highly non-linear and stiff 
mathematical model, the first step, consisting on the determination of PID coefficients 
(KP, KI, KD) by means of Ziegler-Nichols methods, was not sufficient to produce 
satisfactory results. Thus the first attempt values were changed by further manual fine-
tuning, for an optimal result. 
 
4.1 Application of PID controller to the model 
The scheme of the system in presence of the PID controller can be described as shown in 
figure 6: 
In the IPC device, the contact pressure pc is considered as output controlled value, while 
for the regulated value, there are two distinct possibilities. Supply pressure pS and mass 
flow rate Q are two different quantities that can be regulated by PID controller to track the 
reference pC. In the following, both methods to control pC based on regulating pS and Q 
are described.  
 
Figure 6. Scheme of the system with PID controller 
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4.1.1 System control based on regulating pS 
In the simulation and experimental validation shown in figure 5, the supply pressure to the 
system was kept constant and equal to 5·10
4 
 Pa relative. The value of the internal bladder 
pressure and the contact pressure was then determined by the natural dynamic 
characteristic of the pneumatic circuit and by the inflating/deflating times commanded by 
the PLC. If a feedback was available (e.g. the contact pressure or the inner bladder 
pressure), the supply pressure to the system could be regulated by a PID closed loop 
controller for optimal tracking of the desired value. This can be done by proper integration 
of an electro-pneumatic pressure proportional valve (PPV) into the system. Such 
component will transform the electrical input signal sent by the controller into the supply 
pressure to the IPC device. 
 
Figure 7. Block scheme of the system with supply pressure (Ps) controlled by pressure proportional 
valve (PPV); contact pressure (Pc) is the outlet from bladder (B) 
Figure 7 shows the block scheme of the single-bladder system with supply pressure 
controlled by pressure proportional valve (PPV). 
To design the PID control, the mathematical model of the PPV has been integrated in the 
model. The parameters of the device were maintained as reported in table 1. The model of 
the PPV can be represented by the block diagram shown in figure 8 [26], where Kv is the 
flow coefficient, Tv is the time constant and Cv is the interior capacity of the proportional 
valve. Pin and Pout are the input and the output pressure of the proportional valve 
respectively. For a commercial proportional valve type Festo MPPE-3-1/4, which has 
been considered in simulations, the parameter values are Kv=5·10
-7
 m
3
/Pa/s , Tv=0.01 s 
and Cv=1.43·10
-8
 m
3
/Pa. 
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Figure 8. Block diagram of a pressure proportional valve 
 
With a reference contact pressure of 3.5·10
4
 Pa relative to the ambient in inflating and 
zero in the deflating state, the best tuning was found with the coefficients: KP= 0.03, KI = 
0, KD = 0.0044, i.e. in this case the best solution corresponds to a PD controller.  
The solution was both simulated and experimentally tested. The PID control was 
implemented on the system by means of a NI PCI 6036E board and the above cited Festo 
proportional valve. A single bladder was placed in a test bench reproducing all conditions 
of table 1, including soft tissue stiffness KM. Figure 9 reports the reference pressure, the 
simulated contact pressure and the bladder actual internal pressure.  
 
Figure 9. Reference and simulated contact pressure with PD control of the bladder supply, compared 
with the experimental internal bladder pressure 
Result of figure 9 shows the effectiveness of the control: both the simulated contact 
pressure and the actual air pressure inside the bladder reach the desired value in less than 
2 seconds and they are maintained until the end of the inflating phase. It is interesting to 
0 5 10 15 20 25
0
0.5
1
1.5
2
2.5
3
3.5
4
x 10
4
Time (s)
P
re
s
s
u
re
 (
P
a
)
 
 
Reference Pc
Simulated Pc
Experimental Pi
Appendix                                                                                                                        142 
 
 
note that the controller regulates the bladder air pressure at a slightly greater value than 
the desired contact pressure, taking into account the bladder stiffness. 
To obtain this result, the controller must command in a proper way the proportional valve: 
this is testified by figure 10, which shows the variation of the absolute supply pressure PS, 
operated by the pressure proportional valve. At the beginning of the inflating phase, the 
supply pressure reaches the saturation level (2 bar absolute), so speeding up as much as 
possible the rising of the bladder and contact pressures. 
 
Figure 10. Supply pressure controlled by the proportional valve 
 
The saturation level of the supply pressure, which can be set by the controller, determines 
the response speed of the system, in particular the rising time of the bladder pressure. 
Defining the rising time as the time required for actual bladder pressure to rise from 10% 
to 90% of the reference value, figure 11 shows the variation of the rising time versus the 
saturation level of the supply pressure, as calculated by the mathematical model. 
Therefore the curve of figure 11 can be used to choose the most convenient value for the 
saturation level of the pressure proportional valve. 
A further sensitivity analysis was performed to investigate the influence on system 
performance of the soft tissue stiffness KM, which was recognized as a very critical 
parameter to be identified. Like in the previous case, the rising time of bladder pressure in 
inflating phase was considered to represent the IPC dynamic performance.  
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Figure 11. Rising time versus saturation value of Ps  
 
Figure 12 shows the result of the analysis: for KM varying from 7 to 3 MPa/m, the rising 
time increases of about 38%. This is certainly a noteworthy indication, that suggests the 
search for more effective control solutions in the continuation of research. 
 
Figure 12. Rising time versus soft tissue stiffness KM  
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4.1.2 Control of the system based on regulating Q 
The air pressure inside the bladder can be controlled directly by regulating the air flow 
rate. In this case, the supply to the bladder must be controlled by an electro-pneumatic 
flow-proportional valve (FPV), commanded by the PID control. In fact, referring to 
equation (2), the mass flow rate Q entering the bladder is directly related to the derivative 
of the pressure; therefore, to control the pressure it will be necessary to act on the valve 
conductance C, as defined in equation (1). 
Figure 13 shows the scheme of such a system. In particular, FPV is a 3-way flow 
proportional valve, whose conductance C can be regulated in analogical way by the 
controller. 
 
 
Figure 13. Scheme of the single-bladder system with PID controller and flow proportional valve 
(FPV) 
 
Figure 14 shows a block scheme of an electro-pneumatic flow-proportional valve [27], 
where K is the electro-pneumatic gain and Tv is the time constant of the valve. Referring 
to a commercial proportional valve type Martonair SPGB 18913, the characteristic values 
are: K=1·10
-9
  m
3
/Pa/s/A and Tv=0.1 s. 
Applying to the system the mixed Ziegler-Nichols plus manual tuning method previously 
described, the PID coefficients have been calculated. The optimal result has been obtained 
with KP=0.005, KI=0 and KD=0.001. Also in this case the best configuration corresponds 
to a Proportional-Derivative PD controller. 
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Figure 14. Block diagram of a flow proportional valve 
 
The mathematical model including the optimized PID controller and the flow-proportional 
valve has then been simulated. Figure 15 reports the result of the simulation, showing a 
comparison between the actual and reference contact pressure.The result is very similar to 
the one produced by the control with regulation of the supply pressure: this confirms that 
also the solution with flow regulation is theoretically able to control the device in an 
effective manner. 
 
Figure 15. Reference and actual contact pressure of the bladder with PID control and the flow rate 
regulated by a proportional valve 
 
Figure 16 shows the variation of the valve conductance, under the regulation of the PID 
controller. A positive value corresponds to inflating condition, and vice-versa. 
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Figure 16. Valve conductance variation versus time. 
 
4.1.3 Parallel control of 3 bladders by one pressure proportional valve 
In section 4.1.1 the way to control a single bladder with one pressure proportional valve 
and a PID controller was described. Actually, an IPC device includes a given number of 
bladders, which must be controlled in a coordinated way, in order to generate a definite 
pressure pattern on the limb surface. It is supposed that the device should generate a 
peristaltic and centripetal pressure wave, i.e. proceeding from distal to proximal position, 
in order to facilitate the venous blood return to the heart. To this aim, the activation 
sequence of the bladders must follow the same logic. Thus a definite reference pressure 
must be tracked in any bladder. In addition, for cost and complexity reasons, it would not 
be permissible to have a proportional valve for each bladder. Therefore, a system of three 
bladders controlled by one PID controller and one pressure proportional valve has been 
studied and simulated.  
For such a multi-bladder system the controller, acting as a PLC, must switch among the 
bladders, commanding the proper on-off control valve, selecting the proper contact 
pressure feedback and sending the proper pressure reference to the PID controller. A 
possible scheme of the system is presented in figure 17, where, posing n=1,2,3, Bn are the 
bladders, Vn are the corresponding on-off control valves, Pn are the bladder-limb actual 
contact pressures, PPV is the pressure-proportional electro-valve. 
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Figure 17. Three-bladder system with one pressure-proportional valve (PPV) controlled by PID 
 
In the model the three bladders were configured with different parameters, including the 
contact area A, the soft tissue stiffness KM of the leg region where the bladder acts on, and 
the gap between the bladder and leg d0. The values of such parameters, which are shown 
in table 3, were selected in such a way as to represent possible variations due to muscular 
condition, location of the bladder on the limb and different device dressing that may occur 
using the actual prototype. In particular, with parameter values of table 3, the system is 
configured in such a way as to present increasing response time from bladder 1 to bladder 
3. 
 
 
Table 3. Parameters of the 3 bladders 
 Contact area A  
(m
2
) 
Soft tissue stiffness KM 
(Pa/m) 
Gap d0  
(m) 
Bladder 1 0.014 7.10
6
 0.006 
Bladder 2 0.017 6.10
6
 0.009 
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Bladder 3 0.02 5.10
6
 0.012 
 
The inflating and deflating times, imposed by the PLC for each bladder, were 4 s and 9 s 
respectively, and the three cycles were shifted to produce a peristaltic effect, as it is shown 
in the command sequence of figure 18. When command is OFF the reference pressure is 
0, when command is ON the reference pressure is set at a defined value for all bladders. 
 
Figure 18. Command sequence of the three bladders 
 
The system was simulated in two conditions: 
c) Without proportional valve and PID control: each control valve Vn is supplied at 
5·10
4
 Pa relative pressure 
d) With proportional valve and PID control: the absolute supply pressure to the 
valves Vn is regulated by the proportional valve and is saturated at 2·10
5
 Pa; the 
relative reference pressure to the PID is set to 3.5·10
4
 Pa in inflating state and 0 in 
deflating state, for all bladders. 
Figure 19 shows the simulation results without PID controller (a) and with PID controller 
(b). 
The simulation shows that an effective control of the bladder actions is almost impossible 
without a feedback control system, since the dynamic behavior and the maximum level of 
the pressures are affected by a number of randomness that are difficult to evaluate 
properly. As it can be observed in figure 19(a), the dynamic behavior and the maximum 
level of the contact pressure are very different among the bladders, due to the differences 
imposed to the bladder parameters. On the contrary, when the PID controller acts on the 
system (figure 19 (b)), the contact pressure tracks much better the reference one, which is 
set at 3.5·10
4
 Pa, in each bladder. Obviously the feedback controller gives better result, 
and simply including feedback in the control of on/off valves would guarantee achieving 
of the desired pressure, but the use of a pressure proportional valve provides advantage 
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also for the system dynamics and general tracking: in this case the bladders can be 
supplied with pressure much higher than the desired internal value, thus reducing the 
rising time and allowing to maintain the desired value for a defined period, as highlighted 
by figures 10 and 11. 
 
 
 
 (a) (b) 
 
Figure 19. Simulation of the multi-bladder system in absence (a) and in presence (b) of the PID 
controller   
 
Due to the difference in the bladder parameters, the dynamic behaviors of the three 
bladders are still different, as highlighted by the rise and fall times, but each bladder can 
reach the reference contact pressure and maintains it for a significant time: totally, in a 
cycle of 13 s, the bladders 1, 2 and 3 can stay about 8 s in the reference contact pressure, 
that is equal to 62% of the whole time. You should also consider that the tuning of the 
PID coefficients has been made for only one bladder, but gives acceptable results for the 
whole system, thus testifying the ability to compensate in some extent also uncertainties 
like the actual value of the soft tissue stiffness and the limb/device gap. 
 
Conclusion 
This study concerned the effective control of an IPC device, conceived as a multi-bladder 
system able to realize important rehabilitation action on the cardio-circulatory system of 
people with very serious mobility problems. The main issue was to individuate a proper 
control strategy able to create a defined pressure pattern on the limb surface, 
corresponding to a peristaltic and centripetal pressure wave. To solve this problem we 
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decided to apply a PID control properly tuned and to use proportional components for 
regulation of the pneumatic quantities of the system. 
First a mathematical model of one bladder and its interaction with the human has been 
realized and experimentally validated. The comparison has shown good correspondence 
between experiment and simulation, in both dynamic behavior and maximum level of 
internal bladder pressure. The model is also able to calculate the contact pressure PC 
between bladder and limb. 
Then two different strategies to control the bladder pressure have been studied, 
considering the use of proportional electro-pneumatic components for regulation of the 
two basic quantities acting in the system: i.e. the supply pressure and the air flow to the 
bladders. 
The first method is based on the use of an electro-pneumatic pressure-proportional valve, 
the second involves the use of a flow-proportional valve. In both solutions the PID control 
must track a desired trend of the pressure, trying to reach and maintain a defined value for 
a given time. 
The results produced by the two different controls are similar, as reported in figures 9 and 
15. In both methods the bladder exerts to the limb the exact value of the reference 
pressure for about the 60% of the desired active time (4 s). This is an excellent result, 
taking into consideration the natural low dynamics of such pneumatic systems. On the 
contrary, in absence of PID control the bladder pressure evolves only reaching a peak 
value, whose value is determined by the various parameters of the pneumatic circuit and is 
practically impossible to foresee. 
The choice between the two methods must then consider the general cost and complexity 
of the device, since it is made up of a given number of bladders intended to generate a 
proper pressure wave on the limb surface. In this regard, while the adoption of the flow-
proportional method would require one proportional valve for each bladder, the method 
based on the pressure-proportional valve can allow to realize the whole control system 
with only one proportional valve, thus limiting the cost and complexity of the device. The 
simulation of a system with three bladders fed by one pressure-proportional valve 
demonstrated the feasibility and effectiveness of such a system.  
In conclusion, the study permitted to individuate an effective way to control such a multi-
bladder pneumatic system, capable of providing adequate performance for a positive 
effect on the cardiovascular system. The optimal solution, based on PID control of one 
pressure-proportional electro-pneumatic valve, presents adequate for the realization of a 
quite inexpensive device, suitable for simple and comfortable use. 
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Future work will concern more accurate modeling of the physiological system, including 
also damping characteristic of the soft tissues and a complete model of the cardio-
circulatory system. This will allow to estimate the effect of the IPC device on the dynamic 
performance of the CCS, which is the final goal of the research. On this base, it will be 
possible to define also more precise patterns for the pressing action, that will constitute 
the reference for the study of more performing control algorithms. 
The effectiveness of the IPC device will be verified by means of clinical testing both on 
healthy and impaired people. 
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